[{"symbol": "OCX", "name": "OncoCyte Corporation", "next_earnings_utc": 1589313900, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 5, "next_earnings_revenue_consensus": 0.0, "next_earnings_eps_num_analysts": 5, "next_earnings_eps_consensus": -0.106, "eps_up_revisions": 1, "eps_down_revisions": 4, "revenue_up_revisions": 0, "revenue_down_revisions": 0, "total_analysts": 5, "analysts_sell": 0, "analysts_buy": 4, "analysts_outperform": 1, "analysts_hold": 0, "analysts_underperform": 0, "webpage": "oncocyte.com", "year_founded": 2009, "street_address": "15 Cushing", "city": "Irvine", "state": "CA", "zipcode": "92618", "country": "United States", "phone_number": "949-409-7600", "short_description": "OncoCyte Corporation engages in the development and commercialization of non-invasive blood-based diagnostic tests for the early detection of cancer.", "long_description": "OncoCyte Corporation engages in the development and commercialization of non-invasive blood-based diagnostic tests for the early detection of cancer. The company is developing DetermaVu, a non-invasive molecular lung cancer confirmatory diagnostic that is administered to patients as a blood test. It also develops diagnostic tests based on liquid biopsies for detecting breast cancer. The company was founded in 2009 and is headquartered in Irvine, California.", "industry_name": "Biotechnology", "sector_name": "Health Care", "is_defunct": false, "exchange": "NYSEMKT", "equity_type": "stocks", "market_cap": 188882315, "total_enterprise": 172367315, "number_of_employees": 33, "outstanding_shares": 67217906, "eps": -0.437188, "diluted_eps": -0.437188, "earnings_from_cont_operations": -22426000, "gross_profit": null, "cash": 22451000, "total_debt": 5936000, "total_revenue": null, "cash_from_operations": -19715000, "net_income": -22426000, "ebitda": -21495000, "year_low_stock_price": 1.5, "year_high_stock_price": 5.6, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/OCX.png"}, {"symbol": "FOE", "name": "Ferro Corporation", "next_earnings_utc": 1589277600, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 4, "next_earnings_revenue_consensus": 246338400.0, "next_earnings_eps_num_analysts": 4, "next_earnings_eps_consensus": 0.1205, "eps_up_revisions": 0, "eps_down_revisions": 3, "revenue_up_revisions": 0, "revenue_down_revisions": 3, "total_analysts": 6, "analysts_sell": 0, "analysts_buy": 3, "analysts_outperform": 0, "analysts_hold": 3, "analysts_underperform": 0, "webpage": "ferro.com", "year_founded": 1919, "street_address": "6060 Parkland Boulevard", "city": "Mayfield Heights", "state": "OH", "zipcode": "44124", "country": "United States", "phone_number": "216 875 5600", "short_description": "Ferro Corporation produces and markets specialty materials in the United States, Europe, the Middle East, Africa, the Asia Pacific, and Latin America.", "long_description": "Ferro Corporation produces and markets specialty materials in the United States, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It operates through two segments, Performance Colors and Glass, and Color Solutions. The company offers frits, porcelain and other glass enamels, glazes, stains, decorating colors, pigments, inks, polishing materials, dielectrics, electronic glasses, and other specialty coatings. It also provides slurry-based polishing products for the semiconductor and optoelectronics industry; decorative coatings for glass and high-performance plastics coatings; digital printing solutions for glass; and dielectrics and electronic ink products for component applications. The company's products are used in appliances, household furnishings, automobiles, industrial products, building and renovation, consumer products, packaging, electronics, and sanitary applications. It markets and sells its products directly, as well as through agents and distributors. The company's customers include manufacturers of ceramic tiles, appliances, construction materials, automobile parts, automobiles, architectural and container glass, and electronic components and devices. Ferro Corporation was founded in 1919 and is headquartered in Mayfield Heights, Ohio.", "industry_name": "Chemicals", "sector_name": "Materials", "is_defunct": false, "exchange": "NYSE", "equity_type": "stocks", "market_cap": 841330381, "total_enterprise": 1599802381, "number_of_employees": 5922, "outstanding_shares": 82241484, "eps": 0.073559, "diluted_eps": 0.072484, "earnings_from_cont_operations": 35392000, "gross_profit": 308816000, "cash": 96202000, "total_debt": 844848000, "total_revenue": 1018366000, "cash_from_operations": 17710000, "net_income": 6038000, "ebitda": 137365000, "year_low_stock_price": 7.52, "year_high_stock_price": 16.06, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/FOE.png"}, {"symbol": "AVNW", "name": "Aviat Networks, Inc.", "next_earnings_utc": 1589313600, "next_earnings_has_time": true, "next_earnings_name": "2020 Q3", "next_earnings_year": 2020, "next_earnings_quarter": 3, "next_earnings_revenue_num_analysts": 2, "next_earnings_revenue_consensus": 58388500.0, "next_earnings_eps_num_analysts": 2, "next_earnings_eps_consensus": 0.25, "eps_up_revisions": 0, "eps_down_revisions": 1, "revenue_up_revisions": 0, "revenue_down_revisions": 0, "total_analysts": 2, "analysts_sell": 0, "analysts_buy": 2, "analysts_outperform": 0, "analysts_hold": 0, "analysts_underperform": 0, "webpage": "aviatnetworks.com", "year_founded": 2006, "street_address": "200 Parker Drive", "city": "Austin", "state": "TX", "zipcode": "78728", "country": "United States", "phone_number": "408-941-7100", "short_description": "Aviat Networks, Inc. designs, manufactures, and sells a range of wireless networking products, solutions, and services worldwide.", "long_description": "Aviat Networks, Inc. designs, manufactures, and sells a range of wireless networking products, solutions, and services worldwide. Its products include broadband wireless access base stations and customer premises equipment for fixed and mobile networks; and point-to-point digital microwave radio systems for access, backhaul, trunking, and license-exempt applications, as well as supporting new network deployments, network expansion, and capacity upgrades. The company also offers software tools and applications to enable deployment, monitoring, network management, and optimization of its systems, as well as to automate network design and procurement; and sources, supplies, and supports third party equipment, such as antennas, routers, optical transmission equipment, and other equipment to build and deploy telecommunications transmission network. In addition, it provides a suite of professional services, including planning, deployment, operation, optimization, and maintenance of customers' networks. The company serves mobile and fixed telecommunications network operators, and broadband and Internet service providers and network operators; federal, state, and local government agencies; and transportation, energy, and utility companies, as well as public safety agencies and broadcast network operators. It markets its products through a direct sales, service, and support organization, as well as through original equipment manufacturers and system integrators; indirectly through dealers, resellers, and sales representatives; and through online. The company was formerly known as Harris Stratex Networks, Inc. and changed its name to Aviat Networks, Inc. in January 2010. Aviat Networks, Inc. was incorporated in 2006 and is headquartered in Austin, Texas.", "industry_name": "Communications Equipment", "sector_name": "Information Technology", "is_defunct": false, "exchange": "NASDAQ", "equity_type": "stocks", "market_cap": 52271606, "total_enterprise": 29104606, "number_of_employees": 708, "outstanding_shares": 5397283, "eps": 1.21963, "diluted_eps": 1.189306, "earnings_from_cont_operations": 6561000, "gross_profit": 79730000, "cash": 38067000, "total_debt": 14900000, "total_revenue": 232877000, "cash_from_operations": 14315000, "net_income": 6561000, "ebitda": 5718000, "year_low_stock_price": 7.1, "year_high_stock_price": 15.27, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/AVNW.png"}, {"symbol": "MGY", "name": "Magnolia Oil & Gas Corporation", "next_earnings_utc": 1589288400, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 10, "next_earnings_revenue_consensus": 180472200.0, "next_earnings_eps_num_analysts": 14, "next_earnings_eps_consensus": -0.08119, "eps_up_revisions": 0, "eps_down_revisions": 11, "revenue_up_revisions": 0, "revenue_down_revisions": 7, "total_analysts": 14, "analysts_sell": 0, "analysts_buy": 5, "analysts_outperform": 2, "analysts_hold": 7, "analysts_underperform": 0, "webpage": "magnoliaoilgas.com", "year_founded": null, "street_address": "Nine Greenway Plaza", "city": "Houston", "state": "TX", "zipcode": "77046", "country": "United States", "phone_number": "713 842 9050", "short_description": "Magnolia Oil & Gas Corporation engages in the acquisition, development, exploration, and production of oil, natural gas, and natural gas liquids reserves in the United States.", "long_description": "Magnolia Oil & Gas Corporation engages in the acquisition, development, exploration, and production of oil, natural gas, and natural gas liquids reserves in the United States. The company's properties are located primarily in Karnes County and the Giddings Field in South Texas principally comprising the Eagle Ford Shale and the Austin Chalk formation. As of December 31, 2019, its assets consisted of a total leasehold position of 450,854 net acres, including 22,088 net acres in Karnes, Gonzales, DeWitt, and Atascosa counties, Texas; 428,766 net acres in the Giddings Field; and approximately 1,141 net wells with a total production capacity of 66.8 thousand barrels of oil equivalent per day. The company is headquartered in Houston, Texas.", "industry_name": "Oil, Gas and Consumable Fuels", "sector_name": "Energy", "is_defunct": false, "exchange": "NYSE", "equity_type": "stocks", "market_cap": 843780753, "total_enterprise": 2007486753, "number_of_employees": 45, "outstanding_shares": 168419312, "eps": 0.293002, "diluted_eps": 0.28, "earnings_from_cont_operations": 85005000, "gross_profit": 807430000, "cash": 182633000, "total_debt": 393861000, "total_revenue": 936142000, "cash_from_operations": 647619000, "net_income": 50196000, "ebitda": 671529000, "year_low_stock_price": 3.23, "year_high_stock_price": 13.29, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/MGY.png"}, {"symbol": "DUK", "name": "Duke Energy Corporation", "next_earnings_utc": 1589281200, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 5, "next_earnings_revenue_consensus": 6240567670.0, "next_earnings_eps_num_analysts": 12, "next_earnings_eps_consensus": 1.18382, "eps_up_revisions": 2, "eps_down_revisions": 3, "revenue_up_revisions": 0, "revenue_down_revisions": 1, "total_analysts": 18, "analysts_sell": 0, "analysts_buy": 2, "analysts_outperform": 5, "analysts_hold": 11, "analysts_underperform": 0, "webpage": "duke-energy.com", "year_founded": 2005, "street_address": "550 South Tryon Street", "city": "Charlotte", "state": "NC", "zipcode": "28202-1803", "country": "United States", "phone_number": "704-382-3853", "short_description": "Duke Energy Corporation, together with its subsidiaries, operates as an energy company in the United States.", "long_description": "Duke Energy Corporation, together with its subsidiaries, operates as an energy company in the United States. It operates through three segments: Electric Utilities and Infrastructure, Gas Utilities and Infrastructure, and Commercial Renewables. The Electric Utilities and Infrastructure segment generates, transmits, distributes, and sells electricity in the Carolinas, Florida, and the Midwest; and uses coal, hydroelectric, natural gas, oil, renewable sources, and nuclear fuel to generate electricity. It also engages in the wholesale of electricity to municipalities, electric cooperative utilities, and load-serving entities. This segment serves approximately 7.8 million retail electric customers in 6 states in the Southeast and Midwest regions of the United States covering a service territory of approximately 91,000 square miles; and owns approximately 51,144 megawatts (MW) of generation capacity. The Gas Utilities and Infrastructure segment distributes natural gas to residential, commercial, industrial, and power generation natural gas customers; and owns, operates, and invests in pipeline transmission and natural gas storage facilities. It has approximately 1.6 million customers, including 1.1 million customers in North Carolina, South Carolina, and Tennessee, as well as 535,000 customers in southwestern Ohio and northern Kentucky. The Commercial Renewables segment acquires, owns, develops, builds, and operates wind and solar renewable generation projects, including nonregulated renewable energy and energy storage services to utilities, electric cooperatives, municipalities, and commercial and industrial customers. It has 22 wind, 126 solar, and 1 battery storage facilities, as well as 11 fuel cell locations with a capacity of 2,282 MW across 19 states. The company was formerly known as Duke Energy Holding Corp. and changed its name to Duke Energy Corporation in April 2005. The company was incorporated in 2005 and is headquartered in Charlotte, North Carolina.", "industry_name": "Electric Utilities", "sector_name": "Utilities", "is_defunct": false, "exchange": "NYSE", "equity_type": "stocks", "market_cap": 60028860543, "total_enterprise": 125709860543, "number_of_employees": 28793, "outstanding_shares": 734028620, "eps": 5.057613, "diluted_eps": 5.057613, "earnings_from_cont_operations": 3578000000, "gross_profit": 11560000000, "cash": 311000000, "total_debt": 62901000000, "total_revenue": 24658000000, "cash_from_operations": 8209000000, "net_income": 3748000000, "ebitda": 10881000000, "year_low_stock_price": 62.13, "year_high_stock_price": 103.79, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/DUK.png"}, {"symbol": "HMC", "name": "Honda Motor Co., Ltd.", "next_earnings_utc": 1589267700, "next_earnings_has_time": true, "next_earnings_name": "2020 Q4", "next_earnings_year": 2020, "next_earnings_quarter": 4, "next_earnings_revenue_num_analysts": 7, "next_earnings_revenue_consensus": 30831273021.4684, "next_earnings_eps_num_analysts": null, "next_earnings_eps_consensus": null, "eps_up_revisions": 0, "eps_down_revisions": 1, "revenue_up_revisions": 0, "revenue_down_revisions": 11, "total_analysts": 4, "analysts_sell": 1, "analysts_buy": 2, "analysts_outperform": 1, "analysts_hold": 0, "analysts_underperform": 0, "webpage": "honda.co.jp", "year_founded": 1946, "street_address": "2-1-1, Minami-Aoyama", "city": "Tokyo", "state": null, "zipcode": "107-8556", "country": "Japan", "phone_number": "81 3 3423 1111", "short_description": "Honda Motor Co., Ltd. develops, manufactures, and distributes motorcycles, automobiles, power products, and other products worldwide.", "long_description": "Honda Motor Co., Ltd. develops, manufactures, and distributes motorcycles, automobiles, power products, and other products worldwide. It operates through four segments: Motorcycle Business, Automobile Business, Financial Services Business, and Power Product and Other Businesses. The Motorcycle Business segment produces sports motorcycles, including trial and moto-cross racing, and business and commuter models; and a range of off-road vehicles, such as all-terrain vehicles and side-by-sides. The Automobile Business segment offers passenger cars, light trucks, and mini vehicles, as well as vehicles powered with alternative fuel, such as ethanol, battery electric, and fuel cell vehicles. The Financial Services Business segment provides various financial services, including retail lending and leasing services to customers, as well as other financial services comprising wholesale financing to dealers. The Power Product and Other Businesses segment manufactures and sells power products comprising general purpose engines, generators, water pumps, lawn mowers, riding mowers, robotic mowers, brush cutters, tillers, snow blowers, outboard marine engines, walking assist devices, and portable battery inverter power sources. This segment also offers HondaJet aircraft. The company also sells spare parts; and provides after-sale services through retail dealers directly, as well as through overseas operations, independent distributors and retail dealers, and licensees. Honda Motor Co., Ltd. has a collaboration agreement with Isuzu Motor Company to conduct a joint research project for the usage of hydrogen fuel cells to power heavy-duty trucks. The company was founded in 1946 and is headquartered in Tokyo, Japan.", "industry_name": "Automobiles", "sector_name": "Consumer Discretionary", "is_defunct": false, "exchange": "NYSE", "equity_type": "stocks", "market_cap": 41081613252, "total_enterprise": 89608696000, "number_of_employees": 219722, "outstanding_shares": 1727273030, "eps": 2.47210096352944, "diluted_eps": 2.47207201163229, "earnings_from_cont_operations": 4849175892, "gross_profit": 29753356708, "cash": 22471531248, "total_debt": 67521842762, "total_revenue": 142845918114, "cash_from_operations": 2552193479, "net_income": 4346143582, "ebitda": 11607732163, "year_low_stock_price": 19.38, "year_high_stock_price": 29.44, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/HMC.png"}, {"symbol": "ALC", "name": "Alcon Inc.", "next_earnings_utc": 1589315400, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 9, "next_earnings_revenue_consensus": 1688399440.0, "next_earnings_eps_num_analysts": 12, "next_earnings_eps_consensus": 0.33958, "eps_up_revisions": 0, "eps_down_revisions": 9, "revenue_up_revisions": 0, "revenue_down_revisions": 6, "total_analysts": 20, "analysts_sell": 1, "analysts_buy": 5, "analysts_outperform": 3, "analysts_hold": 10, "analysts_underperform": 1, "webpage": "alcon.com", "year_founded": 1945, "street_address": "Chemin de Blandonnet 8", "city": "Geneva", "state": null, "zipcode": null, "country": "Switzerland", "phone_number": "41 58 911 2110", "short_description": "Alcon, Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients.", "long_description": "Alcon, Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients. It operates through two segments, Surgical and Vision Care. The Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures, such as cataracts, vitreoretinal, refractive laser, and glaucoma surgery. Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR ophthalmic microscope, verion imaged guided system, and ORA System for intra-operative measurements and guidance; vitreoretinal products comprising constellation vision system, grieshaber DSP and MIVS instrumentation, ultravit high speed vitrectomy probes, purepoint laser, and NGENUITY 3D visualization system; refractive surgery products, including WaveLight lasers and diagnostics used for LASIK; and glaucoma product, such as EX-PRESS glaucoma filtration device, as well as AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery. The Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, including devices and over-the-counter products for dry eye, over-the-counter products for contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers under the TOTAL, PRECISION, Dailies, Air Optix, Systane, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon, Inc. in December 2001. Alcon, Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.", "industry_name": "Health Care Equipment and Supplies", "sector_name": "Health Care", "is_defunct": false, "exchange": "NYSE", "equity_type": "stocks", "market_cap": 26306587991, "total_enterprise": 29263527690, "number_of_employees": 22142, "outstanding_shares": 484949066, "eps": -1.343711, "diluted_eps": -1.343711, "earnings_from_cont_operations": -656000000, "gross_profit": 3656000000, "cash": 855000000, "total_debt": 3820000000, "total_revenue": 7508000000, "cash_from_operations": 920000000, "net_income": -656000000, "ebitda": 1451000000, "year_low_stock_price": 39.37, "year_high_stock_price": 65.37, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/ALC.png"}, {"symbol": "XP", "name": "XP Inc.", "next_earnings_utc": 1589313600, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 5, "next_earnings_revenue_consensus": 278744200.0, "next_earnings_eps_num_analysts": 6, "next_earnings_eps_consensus": 0.10417, "eps_up_revisions": 2, "eps_down_revisions": 3, "revenue_up_revisions": 0, "revenue_down_revisions": 4, "total_analysts": 9, "analysts_sell": 0, "analysts_buy": 2, "analysts_outperform": 2, "analysts_hold": 4, "analysts_underperform": 1, "webpage": "xpinc.com", "year_founded": 2001, "street_address": "Av. Chedid Jafet, 75", "city": "S\u00c3\u00a3o Paulo", "state": "SP", "zipcode": "04551-065", "country": "Brazil", "phone_number": "55 11 3075 0429", "short_description": "XP Inc. operates technology-driven financial services platform that provides financial products and services in Brazil.", "long_description": "XP Inc. operates technology-driven financial services platform that provides financial products and services in Brazil. It provides broker-dealer services for high-net worth customers and institutional clients; product structuring and capital markets services for corporate clients and issuers of fixed income products; advisory services for mass-affluent and institutional clients; and wealth management services for high-net-worth clients. The company also offers XP Educacao, an online financial education portal that offers seminars, classes, and learning tools to help teach individuals a range of topics, such as basics of investing, techniques, and investment strategies, as well as insurance brokerage services. In addition, it operates XP Platform, an open product platform that provides clients to access investment products in the market, including equity and fixed income securities, mutual and hedge funds, structured products, life insurance, pension plans, real-estate investment funds, and others. The company was founded in 2001 and is based in Sao Paulo, Brazil.", "industry_name": "Capital Markets", "sector_name": "Financials", "is_defunct": false, "exchange": "NASDAQ", "equity_type": "stocks", "market_cap": 13855706185, "total_enterprise": 12354551593, "number_of_employees": 1567, "outstanding_shares": 551800326, "eps": 0.525585908344529, "diluted_eps": 0.525327163258198, "earnings_from_cont_operations": 271056377, "gross_profit": 876187491, "cash": 6261987361, "total_debt": 4760120416, "total_revenue": 1275764542, "cash_from_operations": -948895855, "net_income": 268817236, "ebitda": 418326367, "year_low_stock_price": 15.5, "year_high_stock_price": 43.52, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/XP.png"}, {"symbol": "IR", "name": "Ingersoll Rand Inc.", "next_earnings_utc": 1589279400, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 7, "next_earnings_revenue_consensus": 1273298130.0, "next_earnings_eps_num_analysts": 11, "next_earnings_eps_consensus": 0.27043, "eps_up_revisions": 1, "eps_down_revisions": 3, "revenue_up_revisions": 2, "revenue_down_revisions": 0, "total_analysts": 13, "analysts_sell": 0, "analysts_buy": 3, "analysts_outperform": 4, "analysts_hold": 6, "analysts_underperform": 0, "webpage": "irco.com", "year_founded": 1859, "street_address": "800-A Beaty Street", "city": "Davidson", "state": "NC", "zipcode": "28036", "country": "United States", "phone_number": "414-212-4700", "short_description": "Ingersoll Rand Inc. provides mission-critical flow control and compression equipment, and associated aftermarket parts, consumables, and services in the United States, Europe, the Middle East, Africa, and the Asia Pacific.", "long_description": "Ingersoll Rand Inc. provides mission-critical flow control and compression equipment, and associated aftermarket parts, consumables, and services in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Industrials, Energy, and Medical. The Industrials segment designs, manufactures, markets, and services a range of air compression, vacuum, and blower products, as well as offers associated aftermarket parts, consumables, and services. Its products are used in process-critical applications, such as the operation of industrial air tools, vacuum packaging of food products, aeration of waste water, and others. This segment sells its products through an integrated network of direct sales representatives and independent distributors under the Gardner Denver, CompAir, Elmo Rietschle, Robuschi, and other brand names. The Energy segment designs, manufactures, markets, and services a range of displacement and liquid ring vacuum pumps, compressors and integrated systems, and engineered fluid loading and transfer equipment, as well as offers associated aftermarket parts, consumables, and services under the Gardner Denver, Nash, Emco Wheaton, and other brands. This segment serves customers in upstream, midstream, and downstream energy markets, as well as petrochemical processing, transportation, and general industrial sectors. The Medical segment designs, manufactures, and markets a range of specialized gas, liquid, and precision syringe pumps and compressors under the Thomas and other brands for use in oxygen therapy, blood dialysis, patient monitoring, laboratory sterilization and wound treatment, and other applications. The company was formerly known as Gardner Denver Holdings, Inc. and changed its name to Ingersoll Rand Inc. in March 2020. Ingersoll Rand Inc. was founded in 1859 and is based in Davidson, North Carolina.", "industry_name": "Machinery", "sector_name": "Industrials", "is_defunct": false, "exchange": "NYSE", "equity_type": "stocks", "market_cap": 12151089912, "total_enterprise": 13328189912, "number_of_employees": 6600, "outstanding_shares": 416561190, "eps": 0.781818, "diluted_eps": 0.76, "earnings_from_cont_operations": 159100000, "gross_profit": 911700000, "cash": 505500000, "total_debt": 1682600000, "total_revenue": 2451900000, "cash_from_operations": 343300000, "net_income": 159100000, "ebitda": 527200000, "year_low_stock_price": 17.01, "year_high_stock_price": 38.96, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/IR.png"}, {"symbol": "BNTX", "name": "BioNTech SE", "next_earnings_utc": 1589280300, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 6, "next_earnings_revenue_consensus": 26294937.8042185, "next_earnings_eps_num_analysts": 4, "next_earnings_eps_consensus": -0.2949269875608437, "eps_up_revisions": 0, "eps_down_revisions": 2, "revenue_up_revisions": 2, "revenue_down_revisions": 0, "total_analysts": 8, "analysts_sell": 0, "analysts_buy": 3, "analysts_outperform": 0, "analysts_hold": 5, "analysts_underperform": 0, "webpage": "biontech.de", "year_founded": 2008, "street_address": "An der Goldgrube 12", "city": "Mainz", "state": null, "zipcode": "55131", "country": "Germany", "phone_number": "49 6131 9084 0", "short_description": "BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other diseases.", "long_description": "BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other diseases. The company is involved in developing FixVac product candidates, including BNT111, which is in Phase I clinical trial for advance melanoma; BNT112 for prostate cancer; BNT113 that is in Phase I clinical trial to treat HPV+ head and neck cancers; BNT114, which is in Phase I clinical trial for triple negative breast cancer; and BNT115 and BNT116 to treat other cancers, including ovarian cancer. It also develops individualized neo-antigen specific immunotherapies, such as RO7198457, which is in Phase II clinical trial for first-line melanoma, as well as in Phase I clinical trial to treat multiple solid tumors; mRNA intratumoral immunotherapy comprising SAR441000 that is in Phase I clinical trial for solid tumors; and BNT141 and BNT142 to treat multiple solid tumors. In addition, the company develops RiboCytokines, which include BNT151, BNT152, and BNT152 for multiple solid tumors; chimeric antigen receptor T cell immunotherapies, such as BNT211 to treat multiple solid tumors, and BNT212 for pancreatic and other cancers; next-generation checkpoint immunomodulators consisting of GEN1046 and GEN1042, which are in Phase I clinical trial to treat multiple solid tumors. Further, it develops MVT-5873, an IgG1 monoclonal antibody, which is in Phase I clinical trial for pancreatic cancer; BNT411, small molecule immunomodulator product candidate for solid tumors; and infectious disease immunotherapies and rare disease protein replacement therapies. The company has a collaboration with Pfizer Inc. to develop vaccines for the coronavirus using its mRNA-based drug development platform; and development and commercialization collaboration with Shanghai Fosun Pharmaceutical (Group) Co., Ltd. to advance a vaccine candidate BNT162 for the prevention of COVID-19 infections. The company was founded in 2008 and is headquartered in Mainz, Germany.", "industry_name": "Biotechnology", "sector_name": "Health Care", "is_defunct": false, "exchange": "NASDAQ", "equity_type": "stocks", "market_cap": 11166634594, "total_enterprise": 10665437198, "number_of_employees": 1310, "outstanding_shares": 226779744, "eps": -0.953449242849131, "diluted_eps": -0.953449242849131, "earnings_from_cont_operations": -200978127, "gross_profit": 102330903, "cash": 584216489, "total_debt": 83243971, "total_revenue": 121804823, "cash_from_operations": -222699944, "net_income": -200848009, "ebitda": -170836792, "year_low_stock_price": 12.53, "year_high_stock_price": 105.0, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/BNTX.png"}, {"symbol": "DT", "name": "Dynatrace, Inc.", "next_earnings_utc": 1589277600, "next_earnings_has_time": true, "next_earnings_name": "2020 Q4", "next_earnings_year": 2020, "next_earnings_quarter": 4, "next_earnings_revenue_num_analysts": 15, "next_earnings_revenue_consensus": 146314470.0, "next_earnings_eps_num_analysts": 17, "next_earnings_eps_consensus": 0.07698, "eps_up_revisions": 0, "eps_down_revisions": 9, "revenue_up_revisions": 0, "revenue_down_revisions": 6, "total_analysts": 17, "analysts_sell": 0, "analysts_buy": 6, "analysts_outperform": 7, "analysts_hold": 4, "analysts_underperform": 0, "webpage": "dynatrace.com", "year_founded": null, "street_address": "1601 Trapelo Road", "city": "Waltham", "state": "MA", "zipcode": "02451", "country": "United States", "phone_number": "781-530-1000", "short_description": "Dynatrace, Inc. provides a software intelligence platform for the enterprise cloud applications.", "long_description": "Dynatrace, Inc. provides a software intelligence platform for the enterprise cloud applications. It offers Dynatrace, a platform for running an enterprise cloud. The company\u00e2\u20ac\u2122s products include AppMon, Classic Real User Monitoring, Network Application Monitoring, and Synthetic Classic. Its platform allows its customers to modernize and automate IT operations, develop and release software, and enhance user experiences. The company also offers implementation, consulting, and training services. Dynatrace, Inc. markets its products through a combination of direct sales team and a network of partners, including resellers, system integrators, and managed service providers. It serves customers in various industries comprising banking, insurance, retail, manufacturing, travel, and software. The company operates in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. Dynatrace, Inc. is headquartered in Waltham, Massachusetts.", "industry_name": "Software", "sector_name": "Information Technology", "is_defunct": false, "exchange": "NYSE", "equity_type": "stocks", "market_cap": 8766328924, "total_enterprise": 9118009924, "number_of_employees": 1981, "outstanding_shares": 280792086, "eps": -1.764069, "diluted_eps": -1.764069, "earnings_from_cont_operations": -495324000, "gross_profit": 400831000, "cash": 188555000, "total_debt": 540236000, "total_revenue": 511394000, "cash_from_operations": -144888000, "net_income": -495324000, "ebitda": -155294000, "year_low_stock_price": 17.05, "year_high_stock_price": 37.07, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/DT.png"}, {"symbol": "ADPT", "name": "Adaptive Biotechnologies Corporation", "next_earnings_utc": 1589313900, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 5, "next_earnings_revenue_consensus": 21520000.0, "next_earnings_eps_num_analysts": 5, "next_earnings_eps_consensus": -0.212, "eps_up_revisions": 1, "eps_down_revisions": 1, "revenue_up_revisions": 1, "revenue_down_revisions": 3, "total_analysts": 5, "analysts_sell": 0, "analysts_buy": 4, "analysts_outperform": 1, "analysts_hold": 0, "analysts_underperform": 0, "webpage": "adaptivebiotech.com", "year_founded": 2009, "street_address": "1551 Eastlake Avenue East", "city": "Seattle", "state": "WA", "zipcode": "98102", "country": "United States", "phone_number": "206 659 0067", "short_description": "Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases.", "long_description": "Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ research service and kit that is used to answer research questions, as well as to discover new prognostic and diagnostic signals. It also provides clonoSEQ diagnostic tests, which include immunosequencing services for use in the detection and monitoring of minimal residual disease in patients with select blood cancers. In addition, the company offers a pipeline of clinical products and services that are used for the diagnosing, monitoring, and treatment of diseases, such as cancer, autoimmune conditions, and infectious diseases. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; and Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test. It serves the life sciences research, clinical diagnostics, and drug discovery customers. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was founded in 2009 and is headquartered in Seattle, Washington.", "industry_name": "Life Sciences Tools and Services", "sector_name": "Health Care", "is_defunct": false, "exchange": "NASDAQ", "equity_type": "stocks", "market_cap": 4567036120, "total_enterprise": 4026777120, "number_of_employees": 453, "outstanding_shares": 126721313, "eps": -1.00585, "diluted_eps": -1.00585, "earnings_from_cont_operations": -68606000, "gross_profit": -7908000, "cash": 576866000, "total_debt": 36607000, "total_revenue": 85071000, "cash_from_operations": 205404000, "net_income": -68606000, "ebitda": -70600000, "year_low_stock_price": 15.19, "year_high_stock_price": 55.12, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/ADPT.png"}, {"symbol": "NOVT", "name": "Novanta Inc.", "next_earnings_utc": 1589281200, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 3, "next_earnings_revenue_consensus": 142609330.0, "next_earnings_eps_num_analysts": 3, "next_earnings_eps_consensus": 0.32333, "eps_up_revisions": 0, "eps_down_revisions": 2, "revenue_up_revisions": 0, "revenue_down_revisions": 2, "total_analysts": 3, "analysts_sell": 0, "analysts_buy": 0, "analysts_outperform": 1, "analysts_hold": 2, "analysts_underperform": 0, "webpage": "novanta.com", "year_founded": 1968, "street_address": "125 Middlesex Turnpike", "city": "Bedford", "state": "MA", "zipcode": "01730", "country": "United States", "phone_number": "781 266 5700", "short_description": "Novanta Inc., together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide.", "long_description": "Novanta Inc., together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide. Its Photonics segment offers photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products for photonics-based applications, such as industrial processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures. The company's Vision segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; wireless, recorder and video integration technologies for operating room integrations; optical data collection and machine vision technologies; radio frequency identification technologies; thermal chart recorders; spectrometry technologies; and embedded touch screen solutions. Its Precision Motion segment offers optical and inductive encoders, precision motors, motion control sub-assemblies, servo drives, air bearings, and air bearing spindles. The company sells its products through its direct sales force, resellers, distributors, and system integrators under the Cambridge Technology, Lincoln Laser, Synrad, Laser Quantum, ARGES, WOM, NDS, NDSsi, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, General Scanning, Celera Motion, MicroE, Applimotion, Zettlex, Ingenia, and Westwind brands. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was founded in 1968 and is headquartered in Bedford, Massachusetts.", "industry_name": "Electronic Equipment, Instruments and Components", "sector_name": "Information Technology", "is_defunct": false, "exchange": "NASDAQ", "equity_type": "stocks", "market_cap": 3066155925, "total_enterprise": 3262879925, "number_of_employees": 2290, "outstanding_shares": 35122061, "eps": 1.163945, "diluted_eps": 1.15, "earnings_from_cont_operations": 40773000, "gross_profit": 263355000, "cash": 78944000, "total_debt": 275668000, "total_revenue": 626099000, "cash_from_operations": 63248000, "net_income": 40773000, "ebitda": 111120000, "year_low_stock_price": 66.44, "year_high_stock_price": 99.79, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/NOVT.png"}, {"symbol": "HLI", "name": "Houlihan Lokey, Inc.", "next_earnings_utc": 1589314500, "next_earnings_has_time": true, "next_earnings_name": "2020 Q4", "next_earnings_year": 2020, "next_earnings_quarter": 4, "next_earnings_revenue_num_analysts": 6, "next_earnings_revenue_consensus": 290190650.0, "next_earnings_eps_num_analysts": 7, "next_earnings_eps_consensus": 0.77398, "eps_up_revisions": 1, "eps_down_revisions": 5, "revenue_up_revisions": 0, "revenue_down_revisions": 5, "total_analysts": 7, "analysts_sell": 0, "analysts_buy": 1, "analysts_outperform": 3, "analysts_hold": 3, "analysts_underperform": 0, "webpage": "hl.com", "year_founded": 1972, "street_address": "10250 Constellation Boulevard", "city": "Los Angeles", "state": "CA", "zipcode": "90067", "country": "United States", "phone_number": "310-788-5200", "short_description": "Houlihan Lokey, Inc., an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial advisory services worldwide.", "long_description": "Houlihan Lokey, Inc., an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial Advisory Services. The Corporate Finance segment offers general financial advisory services; and advises public and private institutions on buy-side and sell-side transactions, leveraged loans, private mezzanine debt, high-yield debt, initial public offerings, follow-ons, convertibles, equity private placements, private equity, and liability management transactions, as well as financial sponsors on various transactions. It also provides financing solutions and capital-raising advisory services for publicly-held and multinational corporations, financial sponsors, and privately-held companies. The Financial Restructuring segment advises debtors, creditors, and other parties-in-interest related to recapitalization/deleveraging transactions. It also provides a range of advisory services, including structuring, negotiation, and confirmation of plans of reorganization; structuring and analysis of exchange offers; corporate viability assessment; litigation support and expert testimony; and procuring debtor in possession financing. The Financial Advisory Services segment offers valuations of various assets, such as companies, illiquid debt and equity securities, and intellectual property. It also provides fairness opinions in connection with M&A and other transactions, and solvency opinions in connection with corporate spin-offs and dividend recapitalizations; and other types of financial opinions. In addition, this segment offers dispute resolution consulting services. It serves corporations, financial sponsors, and government agencies. The company was founded in 1972 and is headquartered in Los Angeles, California.", "industry_name": "Capital Markets", "sector_name": "Financials", "is_defunct": false, "exchange": "NYSE", "equity_type": "stocks", "market_cap": 4019927777, "total_enterprise": null, "number_of_employees": 1354, "outstanding_shares": 65545863, "eps": 2.741163, "diluted_eps": 2.600546, "earnings_from_cont_operations": 170127000, "gross_profit": 1079540000, "cash": 276735000, "total_debt": 155101000, "total_revenue": 1147389000, "cash_from_operations": 242969000, "net_income": 170127000, "ebitda": null, "year_low_stock_price": 41.8, "year_high_stock_price": 63.52, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/HLI.png"}, {"symbol": "VIR", "name": "Vir Biotechnology, Inc.", "next_earnings_utc": 1589284800, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 3, "next_earnings_revenue_consensus": 2933330.0, "next_earnings_eps_num_analysts": 4, "next_earnings_eps_consensus": -0.55678, "eps_up_revisions": 0, "eps_down_revisions": 2, "revenue_up_revisions": 0, "revenue_down_revisions": 0, "total_analysts": 5, "analysts_sell": 1, "analysts_buy": 1, "analysts_outperform": 1, "analysts_hold": 1, "analysts_underperform": 1, "webpage": "vir.bio", "year_founded": 2016, "street_address": "499 Illinois Street", "city": "San Francisco", "state": "CA", "zipcode": "94158", "country": "United States", "phone_number": "415-906-4324", "short_description": "Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases.", "long_description": "Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; VIR-1111 for the prevention of human immunodeficiency virus; and VIR-2020 for the prevention of tuberculosis. The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited and Brii Biosciences Offshore Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; a collaboration, license, and option agreement with Visterra, Inc.; license agreements with The Rockefeller University and MedImmune, Inc.; a collaboration with WuXi Biologics; and a collaborative research agreement with Generation Bio., as well as GlaxoSmithKline Intellectual Property Development Limited, GlaxoSmithKline Biologicals SA., and Alnylam Pharmaceuticals, Inc. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. for the manufacture of SARS-COV-2 antibodies for potential COVID-19 treatment. Vir Biotechnology, Inc. was founded in 2016 and is headquartered in San Francisco, California.", "industry_name": "Biotechnology", "sector_name": "Health Care", "is_defunct": false, "exchange": "NASDAQ", "equity_type": "stocks", "market_cap": 3380849918, "total_enterprise": 2998582918, "number_of_employees": 229, "outstanding_shares": 109803505, "eps": -5.755632, "diluted_eps": -5.755632, "earnings_from_cont_operations": -174683000, "gross_profit": -134981000, "cash": 383436000, "total_debt": 1169000, "total_revenue": 8091000, "cash_from_operations": -129632000, "net_income": -174683000, "ebitda": -169262000, "year_low_stock_price": 11.65, "year_high_stock_price": 75.0, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/VIR.png"}, {"symbol": "RXN", "name": "Rexnord Corporation", "next_earnings_utc": 1589314800, "next_earnings_has_time": true, "next_earnings_name": "2020 Q4", "next_earnings_year": 2020, "next_earnings_quarter": 4, "next_earnings_revenue_num_analysts": 3, "next_earnings_revenue_consensus": 546676300.0, "next_earnings_eps_num_analysts": 10, "next_earnings_eps_consensus": 0.5024, "eps_up_revisions": 1, "eps_down_revisions": 5, "revenue_up_revisions": 2, "revenue_down_revisions": 1, "total_analysts": 11, "analysts_sell": 0, "analysts_buy": 6, "analysts_outperform": 0, "analysts_hold": 5, "analysts_underperform": 0, "webpage": "rexnordcorporation.com", "year_founded": 2006, "street_address": "511 West Freshwater Way", "city": "Milwaukee", "state": "WI", "zipcode": "53204", "country": "United States", "phone_number": "414-643-3739", "short_description": "Rexnord Corporation designs, manufactures, and markets process and motion control, and water management products worldwide.", "long_description": "Rexnord Corporation designs, manufactures, and markets process and motion control, and water management products worldwide. It operates in two segments, Process & Motion Control Platform and Water Management Platform. The company offers table top conveying chain and related accessories, metal conveying and engineered woven metals, gearing and gear drives, conveying equipment, industrial chain, and custom assemblies; custom-engineered, application-specific miniature gearboxes, and motion control assemblies and components used in aerospace, defense, medical equipment, robotics, semiconductor, instrumentation, and satellite communications; and shaft management products, including couplings, torque limiters, electromagnetic clutches and brakes, industrial bearings, and shaft locking assemblies. It also provides aerospace components for use in door systems, engine accessories and controls, engine mounts, flight control systems, gearboxes, landing gears, and rotor pitch controls. In addition, the company offers valve, distribution and drainage, and site work products; water conservation products; and commercial electric hand dryers. It sells products through distribution partners, independent sales representatives, plumbing wholesalers, industry-specific distributors, and sales agencies to commercial construction, institutional, infrastructure, and residential construction end market, as well as to original equipment manufacturers and end users. The company offers its products under the Rexnord, Rex, Addax, Euroflex, Falk, FlatTop, Cambridge, Link-Belt, Omega, PSI, Shafer, Stearns, Highfield, Thomas, Centa, and Tollok, Zurn, Wilkins, Green Turtle, and World Dryer, Aquaflush, AquaSense, AquaVantage, AquaSpec, EcoVantage, Zurn One, and Zurn One Systems names. Rexnord Corporation was incorporated in 2006 and is headquartered in Milwaukee, Wisconsin.", "industry_name": "Machinery", "sector_name": "Industrials", "is_defunct": false, "exchange": "NYSE", "equity_type": "stocks", "market_cap": 3385072804, "total_enterprise": 4307172804, "number_of_employees": 6700, "outstanding_shares": 121809025, "eps": 1.662849, "diluted_eps": 1.607305, "earnings_from_cont_operations": 201300000, "gross_profit": 805500000, "cash": 277000000, "total_debt": 1196500000, "total_revenue": 2058800000, "cash_from_operations": 287500000, "net_income": 198800000, "ebitda": 427900000, "year_low_stock_price": 18.87, "year_high_stock_price": 35.64, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/RXN.png"}, {"symbol": "NVST", "name": "Envista Holdings Corporation", "next_earnings_utc": 1589313900, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 9, "next_earnings_revenue_consensus": 569068510.0, "next_earnings_eps_num_analysts": 10, "next_earnings_eps_consensus": 0.09695, "eps_up_revisions": 0, "eps_down_revisions": 10, "revenue_up_revisions": 0, "revenue_down_revisions": 9, "total_analysts": 12, "analysts_sell": 0, "analysts_buy": 6, "analysts_outperform": 2, "analysts_hold": 4, "analysts_underperform": 0, "webpage": "envistaco.com", "year_founded": 2018, "street_address": "Building E", "city": "Brea", "state": "CA", "zipcode": "92821-6208", "country": "United States", "phone_number": "714 817 7000", "short_description": "Envista Holdings Corporation, together with its subsidiaries, develops, manufactures and markets dental products in the United States and internationally.", "long_description": "Envista Holdings Corporation, together with its subsidiaries, develops, manufactures and markets dental products in the United States and internationally. The company operates in two segment, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, prefabricated and custom-built prosthetics, and dental eye loupes to oral surgeons, prosthodontists, and periodontists under the brands, including Nobel Biocare systems, Alpha Bio Tec, Implant Direct, Nobel Procera, and Orascoptic; and brackets and wires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Ormco, Insignia, AOA, and Spark brands. This segment also offers software packages used for the treatment planning of dental implants and prosthetics. The company's Equipment & Consumables segment develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; handpieces and associated consumables; treatment units and other dental practice equipment; endodontic systems and related consumables; and restorative materials and instruments, rotary burs, impression materials, bonding agents and cements, and infection prevention products. This segment offers its products under the Dexis, Gendex, i-CAT, KaVo, Pelton & Crane, Kerr, MetrexTM, Sybron Endo, Total Care, and Pentron brands to dental offices, clinics, and hospitals. The company was incorporated in 2018 and is headquartered in Brea, California.", "industry_name": "Health Care Equipment and Supplies", "sector_name": "Health Care", "is_defunct": false, "exchange": "NYSE", "equity_type": "stocks", "market_cap": 2813019825, "total_enterprise": 4142019825, "number_of_employees": 12500, "outstanding_shares": 159197500, "eps": 1.59765, "diluted_eps": 1.59765, "earnings_from_cont_operations": 217600000, "gross_profit": 1516100000, "cash": 211200000, "total_debt": 1537600000, "total_revenue": 2751600000, "cash_from_operations": 397500000, "net_income": 217600000, "ebitda": 420500000, "year_low_stock_price": 10.08, "year_high_stock_price": 33.3, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/NVST.png"}, {"symbol": "VSH", "name": "Vishay Intertechnology, Inc.", "next_earnings_utc": 1589281200, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 5, "next_earnings_revenue_consensus": 602130140.0, "next_earnings_eps_num_analysts": 5, "next_earnings_eps_consensus": 0.148, "eps_up_revisions": 1, "eps_down_revisions": 2, "revenue_up_revisions": 0, "revenue_down_revisions": 2, "total_analysts": 7, "analysts_sell": 1, "analysts_buy": 1, "analysts_outperform": 0, "analysts_hold": 3, "analysts_underperform": 2, "webpage": "vishay.com", "year_founded": 1962, "street_address": "63 Lancaster Avenue", "city": "Malvern", "state": "PA", "zipcode": "19355-2143", "country": "United States", "phone_number": "610 644 1300", "short_description": "Vishay Intertechnology, Inc. manufactures and supplies discrete semiconductors and passive components in the United States, Europe, Asia, and internationally.", "long_description": "Vishay Intertechnology, Inc. manufactures and supplies discrete semiconductors and passive components in the United States, Europe, Asia, and internationally. The Diodes segment provides rectifiers, small signal diodes, protection diodes, thyristors/silicon-controlled rectifiers, and power modules. The Optoelectronic Components segment offers standard and customer specific optoelectronic components, such as infrared (IR) emitters and detectors, IR remote control receivers, optocouplers, solid-state relays, optical sensors, light-emitting diodes, 7-segment displays, and IR data transceiver modules. The Resistors segment provides film, wirewound, power metal strip, power metal plate, crowbar and steel blade, variable, RF and microwave, high voltage, and non-linear resistors, as well as battery management shunts, thermo fuses, chip fuses, pyrotechnic initiators/igniters, networks/arrays, dividers, and temperature sensors. The Inductors segment offers inductors, transformers, magnetics, and connectors. The Capacitors segment offers tantalum, ceramic, film, power, heavy-current, aluminum electrolytic capacitors, and energy storage capacitors. The company's semiconductor components are used for power control, power conversion, power management, signal switching, signal routing, signal blocking, signal amplification, two-way data transfer, one-way remote control, and circuit isolation functions; and passive components are used to restrict current flow, suppress voltage increases, store and discharge energy, control alternating current and voltage, filter out unwanted electrical signals, and other functions.", "industry_name": "Electronic Equipment, Instruments and Components", "sector_name": "Information Technology", "is_defunct": false, "exchange": "NYSE", "equity_type": "stocks", "market_cap": 2452991574, "total_enterprise": 2250453574, "number_of_employees": 22400, "outstanding_shares": 144548708, "eps": 1.133657, "diluted_eps": 1.13, "earnings_from_cont_operations": 164790000, "gross_profit": 671200000, "cash": 802955000, "total_debt": 597877000, "total_revenue": 2668305000, "cash_from_operations": 296444000, "net_income": 163936000, "ebitda": 436914000, "year_low_stock_price": 11.23, "year_high_stock_price": 23.25, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/VSH.png"}, {"symbol": "CVLT", "name": "Commvault Systems, Inc.", "next_earnings_utc": 1589283000, "next_earnings_has_time": true, "next_earnings_name": "2020 Q4", "next_earnings_year": 2020, "next_earnings_quarter": 4, "next_earnings_revenue_num_analysts": 8, "next_earnings_revenue_consensus": 173028750.0, "next_earnings_eps_num_analysts": 8, "next_earnings_eps_consensus": 0.3775, "eps_up_revisions": 0, "eps_down_revisions": 4, "revenue_up_revisions": 0, "revenue_down_revisions": 4, "total_analysts": 8, "analysts_sell": 0, "analysts_buy": 3, "analysts_outperform": 1, "analysts_hold": 4, "analysts_underperform": 0, "webpage": "commvault.com", "year_founded": 1988, "street_address": "1 Commvault Way", "city": "Tinton Falls", "state": "NJ", "zipcode": "07724", "country": "United States", "phone_number": "732-870-4000", "short_description": "Commvault Systems, Inc. provides data protection and information management software applications and related services in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China.", "long_description": "Commvault Systems, Inc. provides data protection and information management software applications and related services in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. It offers Commvault Complete Backup & Recovery, a backup and recovery solution for enterprises; and Commvault HyperScale Technology, an add-on for Commvault Complete that delivers an on-premises, cloud-like infrastructure to support scale-out secondary storage. The company also provides Commvault Orchestrate, an automated service delivery technology that enables users to provision, sync, and validate data in various environments for IT needs, such as disaster recovery testing, Dev/Test operations, and workload migrations; and Commvault Activate, a solution, which allow customers to comply with privacy regulations. In addition, it sells appliances that integrate the software with hardware for use in a range of business needs and use cases; and offers professional and customer support services. The company sells its software and related services directly through its sales force to large enterprises, small and medium sized businesses, and government agencies, as well as indirectly through its network of value-added resellers, systems integrators, corporate resellers, and original equipment manufacturers. It licenses its software applications to customers in the banking, insurance and financial services, government, healthcare, pharmaceuticals and medical services, technology, legal, manufacturing, utility, and energy industries. The company has strategic relationships with Atos, Cisco, Citrix, Fujitsu, Hewlett Packard Enterprise, Microsoft, Oracle, SAP, and VMware. Commvault Systems, Inc. was founded in 1988 and is headquartered in Tinton Falls, New Jersey.", "industry_name": "Software", "sector_name": "Information Technology", "is_defunct": false, "exchange": "NASDAQ", "equity_type": "stocks", "market_cap": 2094716837, "total_enterprise": 1774656837, "number_of_employees": 2559, "outstanding_shares": 46601042, "eps": -0.366654, "diluted_eps": -0.371764, "earnings_from_cont_operations": -16743000, "gross_profit": 563405000, "cash": 337013000, "total_debt": 16953000, "total_revenue": 687563000, "cash_from_operations": 92594000, "net_income": -16743000, "ebitda": 33035000, "year_low_stock_price": 24.26, "year_high_stock_price": 51.9, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/CVLT.png"}, {"symbol": "PGNY", "name": "Progyny, Inc.", "next_earnings_utc": 1589313900, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 3, "next_earnings_revenue_consensus": 71806420.0, "next_earnings_eps_num_analysts": 4, "next_earnings_eps_consensus": 0.02459, "eps_up_revisions": 0, "eps_down_revisions": 3, "revenue_up_revisions": 0, "revenue_down_revisions": 2, "total_analysts": 4, "analysts_sell": 0, "analysts_buy": 1, "analysts_outperform": 2, "analysts_hold": 1, "analysts_underperform": 0, "webpage": "progyny.com", "year_founded": 2008, "street_address": "1359 Broadway", "city": "New York", "state": "NY", "zipcode": "10018", "country": "United States", "phone_number": "212 888 3124", "short_description": "Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States.", "long_description": "Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption expenses for clients and their employees. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.", "industry_name": "Health Care Providers and Services", "sector_name": "Health Care", "is_defunct": false, "exchange": "NASDAQ", "equity_type": "stocks", "market_cap": 1868305132, "total_enterprise": 1787923132, "number_of_employees": 167, "outstanding_shares": 84845828, "eps": -0.413258, "diluted_eps": -0.413258, "earnings_from_cont_operations": -8569000, "gross_profit": 45505000, "cash": 80382000, "total_debt": 0, "total_revenue": 229683000, "cash_from_operations": -1534000, "net_income": -8569000, "ebitda": 11810000, "year_low_stock_price": 13.29, "year_high_stock_price": 36.5, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/PGNY.png"}, {"symbol": "EGHT", "name": "8x8, Inc.", "next_earnings_utc": 1589313900, "next_earnings_has_time": true, "next_earnings_name": "2020 Q4", "next_earnings_year": 2020, "next_earnings_quarter": 4, "next_earnings_revenue_num_analysts": 15, "next_earnings_revenue_consensus": 119329020.0, "next_earnings_eps_num_analysts": 10, "next_earnings_eps_consensus": -0.372, "eps_up_revisions": 0, "eps_down_revisions": 2, "revenue_up_revisions": 1, "revenue_down_revisions": 6, "total_analysts": 17, "analysts_sell": 1, "analysts_buy": 7, "analysts_outperform": 2, "analysts_hold": 6, "analysts_underperform": 1, "webpage": "8x8.com", "year_founded": 1987, "street_address": "675 Creekside Way", "city": "Campbell", "state": "CA", "zipcode": "95008", "country": "United States", "phone_number": "408-727-1885", "short_description": "8x8, Inc. provides enterprise cloud communications and customer engagement solutions for small and mid-size businesses, mid-market, and distributed enterprises worldwide.", "long_description": "8x8, Inc. provides enterprise cloud communications and customer engagement solutions for small and mid-size businesses, mid-market, and distributed enterprises worldwide. It offers unified communications, team collaboration, conferencing, contact center, analytics, and other services to various business customers on a software-as-a-service (SaaS) model. The company provides 8x8 Virtual Office, a self-contained and end-to-end solution that delivers high quality voice and unified communications-as-a-service; 8x8 Contact Center, a multi-channel cloud-based contact center solution; and 8x8 Meetings, a cloud-based video conferencing and collaboration solution that enables secure and continuous collaboration with borderless high definition (HD) video and audio communications from mobile and desktop devices. It also offers 8x8 Team Messaging, an integrated open team messaging platform, which facilitate modern modes of communication with support; and Script8, a communications flow and routing engine that offers a scripting environment for routing communications data for specific workflows, as well as allows end-users to create simple, personalized, and customizable communications experiences, such as communications control, external data source integration, and intelligent routing. The company integrates its services with third-party applications and platforms, including enterprise resource planning, customer relations management, human capital management, and other proprietary application suites. It markets its services to end users through search engine marketing and optimization, third-party lead generation sources, industry conferences, trade shows, Webinars, and digital advertising channels, as well as direct sales organization. It serves business customers and distributors. 8x8, Inc. was founded in 1987 and is headquartered in Campbell, California.", "industry_name": "Software", "sector_name": "Information Technology", "is_defunct": false, "exchange": "NYSE", "equity_type": "stocks", "market_cap": 1943632736, "total_enterprise": 2106526736, "number_of_employees": 1497, "outstanding_shares": 102458236, "eps": -1.530393, "diluted_eps": -1.530393, "earnings_from_cont_operations": -150399000, "gross_profit": 240326000, "cash": 215077000, "total_debt": 377971000, "total_revenue": 418526000, "cash_from_operations": -71031000, "net_income": -150399000, "ebitda": -123787000, "year_low_stock_price": 10.7, "year_high_stock_price": 26.67, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/EGHT.png"}, {"symbol": "TPTX", "name": "Turning Point Therapeutics, Inc.", "next_earnings_utc": 1589313900, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 7, "next_earnings_revenue_consensus": 0.0, "next_earnings_eps_num_analysts": 6, "next_earnings_eps_consensus": -0.64667, "eps_up_revisions": 3, "eps_down_revisions": 1, "revenue_up_revisions": 0, "revenue_down_revisions": 0, "total_analysts": 8, "analysts_sell": 0, "analysts_buy": 5, "analysts_outperform": 3, "analysts_hold": 0, "analysts_underperform": 0, "webpage": "tptherapeutics.com", "year_founded": 2013, "street_address": "10628 Science Center Drive", "city": "San Diego", "state": "CA", "zipcode": "92121", "country": "United States", "phone_number": "858 926 5251", "short_description": "Turning Point Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in designing and developing novel small molecule targeted oncology therapies.", "long_description": "Turning Point Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in designing and developing novel small molecule targeted oncology therapies. It develops a pipeline of tyrosine kinase inhibitors (TKIs) that targets genetic drivers of cancer in TKI-naive and TKI-pretreated patients. The company's lead drug candidate repotrectinib is being evaluated in an ongoing Phase I/II trial called TRIDENT-1 for the treatment of patients with ROS1+ advanced non-small-cell lung cancer (NSCLC) and patients with ROS1+, NTRK+, or ALK+ advanced solid tumors. Its pipeline also includes multi-targeted drug candidates TPX-0046, a RET/SRC inhibitor; TPX-0022, a MET/CSF1R/SRC inhibitor; and TPX-0131, a preclinical ALK inhibitor. The company was founded in 2013 and is headquartered in San Diego, California.", "industry_name": "Biotechnology", "sector_name": "Health Care", "is_defunct": false, "exchange": "NASDAQ", "equity_type": "stocks", "market_cap": 1917684507, "total_enterprise": 1513588507, "number_of_employees": 91, "outstanding_shares": 35925150, "eps": -2.989895, "diluted_eps": -2.989895, "earnings_from_cont_operations": -72131000, "gross_profit": null, "cash": 409151000, "total_debt": 5055000, "total_revenue": null, "cash_from_operations": -57757000, "net_income": -72131000, "ebitda": -76032000, "year_low_stock_price": 29.0, "year_high_stock_price": 67.54, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/TPTX.png"}, {"symbol": "TAC", "name": "TransAlta Corporation", "next_earnings_utc": 1589281200, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 2, "next_earnings_revenue_consensus": 350886127.4506423, "next_earnings_eps_num_analysts": 4, "next_earnings_eps_consensus": -0.08644038494784763, "eps_up_revisions": 0, "eps_down_revisions": 1, "revenue_up_revisions": 0, "revenue_down_revisions": 1, "total_analysts": 10, "analysts_sell": 0, "analysts_buy": 2, "analysts_outperform": 5, "analysts_hold": 3, "analysts_underperform": 0, "webpage": "transalta.com", "year_founded": 1909, "street_address": "110-12th Avenue SW", "city": "Calgary", "state": "AB", "zipcode": "T2P 2M1", "country": "Canada", "phone_number": "403-267-7110", "short_description": "TransAlta Corporation operates as non-regulated electricity generation and energy marketing company in Canada, the United States, and Western Australia.", "long_description": "TransAlta Corporation operates as non-regulated electricity generation and energy marketing company in Canada, the United States, and Western Australia. It operates through Canadian Coal, U.S. Coal, Canadian Gas, Australian Gas, Wind and Solar, Hydro, and Energy Marketing segments. The company generates and markets electricity through various generation fuels, such as coal, natural gas, water, solar, and wind. It also engages in wholesale trading of electricity and other energy-related commodities and derivatives. The company operates facilities with approximately 8,385 megawatts of aggregate generating capacity. TransAlta Corporation was founded in 1909 and is headquartered in Calgary, Canada.", "industry_name": "Independent Power and Renewable Electricity Producers", "sector_name": "Utilities", "is_defunct": false, "exchange": "NYSE", "equity_type": "stocks", "market_cap": 1611953692, "total_enterprise": 5324380629, "number_of_employees": 1543, "outstanding_shares": 275778741, "eps": 0.141506673135719, "diluted_eps": 0.141506673135719, "earnings_from_cont_operations": 135542053, "gross_profit": 605318485, "cash": 316521498, "total_debt": 2724703309, "total_revenue": 1807484078, "cash_from_operations": 653836379, "net_income": 63150275, "ebitda": 663077883, "year_low_stock_price": 3.63, "year_high_stock_price": 8.5, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/TAC.png"}, {"symbol": "OR", "name": "Osisko Gold Royalties Ltd", "next_earnings_utc": 1589326200, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 2, "next_earnings_revenue_consensus": 27777972.80134709, "next_earnings_eps_num_analysts": 11, "next_earnings_eps_consensus": 0.04216076601452688, "eps_up_revisions": 0, "eps_down_revisions": 3, "revenue_up_revisions": 1, "revenue_down_revisions": 0, "total_analysts": 14, "analysts_sell": 0, "analysts_buy": 4, "analysts_outperform": 7, "analysts_hold": 3, "analysts_underperform": 0, "webpage": "osiskogr.com", "year_founded": null, "street_address": "1100, Avenue des Canadiens-de-Montr\u00c3\u00a9al", "city": "Montreal", "state": "QC", "zipcode": "H3B 2S2", "country": "Canada", "phone_number": "514-940-0670", "short_description": "Osisko Gold Royalties Ltd acquires and manages precious metal and other royalties, streams, and similar interests in Canada and internationally.", "long_description": "Osisko Gold Royalties Ltd acquires and manages precious metal and other royalties, streams, and similar interests in Canada and internationally. Its assets include the 5% net smelter return (NSR) royalty on the Canadian Malartic mine; the 2.0% to 3.5% NSR royalty on the Eleonore mine; 5% NSR royalty on the Dublin Gulch property; a 9.6% diamond stream on the Renard diamond mine; a 3% NSR royalty on the Seabee gold operations located in Saskatchewan, Canada; a 1.5% gross revenue royalty on the Kwale mine; the 1.38% to 2.55% NSR royalty on the Island Gold mine; a 4.22% gold stream and 62.5% silver stream on the Amulsar project; and a 18.5% gold stream and a 75% silver stream on the Back Forty project. The company also has a 100% silver stream on the Mantos Blancos copper mine in Chile. It holds a portfolio of approximately 135 royalties, streams, and precious metal offtakes in North America; and owns rights to participate in future royalty/stream financings on various projects primarily in Canada. Osisko Gold Royalties Ltd is headquartered in Montreal, Canada.", "industry_name": "Metals and Mining", "sector_name": "Materials", "is_defunct": false, "exchange": "NYSE", "equity_type": "stocks", "market_cap": 1581297063, "total_enterprise": 1746627160, "number_of_employees": 40, "outstanding_shares": 165326270, "eps": -1.19233263251931, "diluted_eps": -1.19369421404863, "earnings_from_cont_operations": -180359494, "gross_profit": 99899114, "cash": 99289944, "total_debt": 276605134, "total_revenue": 302350422, "cash_from_operations": 70541937, "net_income": -180359494, "ebitda": 77770333, "year_low_stock_price": 4.65, "year_high_stock_price": 13.43, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/OR.png"}, {"symbol": "RLJ", "name": "RLJ Lodging Trust", "next_earnings_utc": 1589315400, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 8, "next_earnings_revenue_consensus": 261407050.0, "next_earnings_eps_num_analysts": 2, "next_earnings_eps_consensus": -0.16022, "eps_up_revisions": 0, "eps_down_revisions": 0, "revenue_up_revisions": 0, "revenue_down_revisions": 6, "total_analysts": 11, "analysts_sell": 1, "analysts_buy": 3, "analysts_outperform": 2, "analysts_hold": 5, "analysts_underperform": 0, "webpage": "rljlodgingtrust.com", "year_founded": 2000, "street_address": "3 Bethesda Metro Center", "city": "Bethesda", "state": "MD", "zipcode": "20814", "country": "United States", "phone_number": "301-280-7777", "short_description": "RLJ Lodging Trust is a self-advised, publicly traded real estate investment trust that owns primarily premium-branded, high-margin, focused-service and compact full-service hotels.", "long_description": "RLJ Lodging Trust is a self-advised, publicly traded real estate investment trust that owns primarily premium-branded, high-margin, focused-service and compact full-service hotels. The Company's portfolio consists of 103 hotels with approximately 22,570 rooms, located in 23 states and the District of Columbia and an ownership interest in one unconsolidated hotel with 171 rooms.", "industry_name": "Equity Real Estate Investment Trusts (REITs)", "sector_name": "Real Estate", "is_defunct": false, "exchange": "NYSE", "equity_type": "stocks", "market_cap": 1523900867, "total_enterprise": 3369259867, "number_of_employees": 87, "outstanding_shares": 167645860, "eps": 0.591901, "diluted_eps": 0.59, "earnings_from_cont_operations": 129379000, "gross_profit": 490151000, "cash": 886774000, "total_debt": 2341048000, "total_revenue": 1567859000, "cash_from_operations": 397325000, "net_income": 129181000, "ebitda": 442844000, "year_low_stock_price": 3.88, "year_high_stock_price": 19.04, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/RLJ.png"}, {"symbol": "FLOW", "name": "SPX FLOW, Inc.", "next_earnings_utc": 1589279400, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 6, "next_earnings_revenue_consensus": 309783250.0, "next_earnings_eps_num_analysts": 7, "next_earnings_eps_consensus": 0.03143, "eps_up_revisions": 0, "eps_down_revisions": 4, "revenue_up_revisions": 0, "revenue_down_revisions": 3, "total_analysts": 7, "analysts_sell": 1, "analysts_buy": 3, "analysts_outperform": 0, "analysts_hold": 1, "analysts_underperform": 2, "webpage": "spxflow.com", "year_founded": null, "street_address": "13320 Ballantyne Corporate Place", "city": "Charlotte", "state": "NC", "zipcode": "28277", "country": "United States", "phone_number": "704 752 4400", "short_description": "SPX FLOW, Inc. provides various engineered solutions worldwide.", "long_description": "SPX FLOW, Inc. provides various engineered solutions worldwide. It operates in two segments: Food and Beverage, and Industrial. The Food and Beverage segment offers homogenizers, pumps, valves, separators, and heat exchangers, primarily under the, APV, Gerstenberg Schroeder, Seital and Waukesha Cherry-Burrell brands. The Industrial segment offers air dryers, filtration equipment, mixers, pumps, hydraulic technologies, and heat exchangers primarily under the Airpel, APV, Bolting Systems, Bran+Luebbe, Deltech, Hankison, Jemaco, Johnson Pump, LIGHTNIN, Power Team and Stone brands. This segment primarily serves customers in the chemical, air treatment, mining, pharmaceutical, marine, shipbuilding, infrastructure construction, general industrial, and water treatment industries. The company is headquartered in Charlotte, North Carolina.", "industry_name": "Machinery", "sector_name": "Industrials", "is_defunct": false, "exchange": "NYSE", "equity_type": "stocks", "market_cap": 1372139110, "total_enterprise": 1853939110, "number_of_employees": 5000, "outstanding_shares": 42639500, "eps": -2.239491, "diluted_eps": -2.239491, "earnings_from_cont_operations": 56600000, "gross_profit": 520400000, "cash": 299200000, "total_debt": 770300000, "total_revenue": 1506600000, "cash_from_operations": 173300000, "net_income": -95100000, "ebitda": 168800000, "year_low_stock_price": 15.74, "year_high_stock_price": 49.94, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/FLOW.png"}, {"symbol": "SWAV", "name": "ShockWave Medical, Inc.", "next_earnings_utc": 1589313900, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 5, "next_earnings_revenue_consensus": 14174760.0, "next_earnings_eps_num_analysts": 5, "next_earnings_eps_consensus": -0.496, "eps_up_revisions": 1, "eps_down_revisions": 3, "revenue_up_revisions": 1, "revenue_down_revisions": 3, "total_analysts": 6, "analysts_sell": 1, "analysts_buy": 3, "analysts_outperform": 1, "analysts_hold": 1, "analysts_underperform": 0, "webpage": "shockwavemedical.com", "year_founded": 2009, "street_address": "5403 Betsy Ross Drive", "city": "Santa Clara", "state": "CA", "zipcode": "95054", "country": "United States", "phone_number": "510 279 4262", "short_description": "ShockWave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy technology to treat calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases.", "long_description": "ShockWave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy technology to treat calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases. The company offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee peripheral artery disease. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company operates in the United States, Germany, rest of Europe, and internationally. ShockWave Medical, Inc. was incorporated in 2009 and is headquartered in Santa Clara, California.", "industry_name": "Health Care Equipment and Supplies", "sector_name": "Health Care", "is_defunct": false, "exchange": "NASDAQ", "equity_type": "stocks", "market_cap": 1300616432, "total_enterprise": 1127985432, "number_of_employees": 284, "outstanding_shares": 31862235, "eps": -2.138019, "diluted_eps": -2.138019, "earnings_from_cont_operations": -51109000, "gross_profit": 25768000, "cash": 195349000, "total_debt": 22718000, "total_revenue": 42927000, "cash_from_operations": -48107000, "net_income": -51109000, "ebitda": -50502000, "year_low_stock_price": 22.01, "year_high_stock_price": 68.39, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/SWAV.png"}, {"symbol": "ALGT", "name": "Allegiant Travel Company", "next_earnings_utc": 1589313600, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 5, "next_earnings_revenue_consensus": 409474150.0, "next_earnings_eps_num_analysts": 6, "next_earnings_eps_consensus": 1.01901, "eps_up_revisions": 0, "eps_down_revisions": 6, "revenue_up_revisions": 0, "revenue_down_revisions": 5, "total_analysts": 10, "analysts_sell": 0, "analysts_buy": 4, "analysts_outperform": 1, "analysts_hold": 4, "analysts_underperform": 1, "webpage": "allegiantair.com", "year_founded": 1997, "street_address": "1201 North Town Center Drive", "city": "Las Vegas", "state": "NV", "zipcode": "89144", "country": "United States", "phone_number": "702 851 7300", "short_description": "Allegiant Travel Company, a leisure travel company, provides travel services and products to residents of under-served cities in the United States.", "long_description": "Allegiant Travel Company, a leisure travel company, provides travel services and products to residents of under-served cities in the United States. The company offers scheduled air transportation on limited-frequency, nonstop flights between under-served cities and leisure destinations. As of February 14, 2020, it operated a fleet of 94 Airbus A320 series aircraft. The company also provides air-related services and products in conjunction with air transportation, including convenience fees, advance seat assignments, travel protection products, change fees, priority boarding, food and beverage purchases on board, and other air-related services, as well as use of its call center for purchases. In addition, it offers third party travel products, such as hotel rooms and ground transportation, such as rental cars and hotel shuttle products; and air transportation services through fixed fee agreements and charter service on a year-round and ad-hoc basis. Further, the company leases spare engines to a third party; offers management solutions to golf courses; and operates a golf course and family entertainment centers. Allegiant Travel Company was founded in 1997 and is headquartered in Las Vegas, Nevada.", "industry_name": "Airlines", "sector_name": "Industrials", "is_defunct": false, "exchange": "NASDAQ", "equity_type": "stocks", "market_cap": 1212260468, "total_enterprise": 2200249468, "number_of_employees": 4363, "outstanding_shares": 16075593, "eps": 14.269919, "diluted_eps": 14.257652, "earnings_from_cont_operations": 232117000, "gross_profit": 673557000, "cash": 457816000, "total_debt": 1445805000, "total_revenue": 1840965000, "cash_from_operations": 442210000, "net_income": 232117000, "ebitda": 473127000, "year_low_stock_price": 60.06, "year_high_stock_price": 183.26, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/ALGT.png"}, {"symbol": "INFN", "name": "Infinera Corporation", "next_earnings_utc": 1589313900, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 13, "next_earnings_revenue_consensus": 318307540.0, "next_earnings_eps_num_analysts": 15, "next_earnings_eps_consensus": -0.18342, "eps_up_revisions": 0, "eps_down_revisions": 15, "revenue_up_revisions": 4, "revenue_down_revisions": 8, "total_analysts": 15, "analysts_sell": 2, "analysts_buy": 5, "analysts_outperform": 2, "analysts_hold": 6, "analysts_underperform": 0, "webpage": "infinera.com", "year_founded": 2000, "street_address": "140 Caspian Court", "city": "Sunnyvale", "state": "CA", "zipcode": "94089", "country": "United States", "phone_number": "408 572 5200", "short_description": "Infinera Corporation provides optical transport networking equipment, software, and services worldwide.", "long_description": "Infinera Corporation provides optical transport networking equipment, software, and services worldwide. The company's product portfolio includes Infinera Groove series of modular and sled-based platforms to support a variety of transport network applications; 7300 series, an SDN-ready coherent optical transport system; FlexILS open line system platform that connects various Infinera and third-party terminal equipment platforms over long-distance fiber optic cable providing switching, multiplexing, amplification, and management channels; and 7090 and 7100 series packet transport platforms. It also offers Infinera XTM series packet-optical transport platform that enables high performance metro networks with service-aware, application-specific capabilities; XTC series multi-terabit packet optical transport platforms that integrate digital OTN switching and optical WDM transmission; mTera series universal transport platform; and XT series for long-haul and subsea applications. In addition, the company Infinera Cloud Xpress Family designed to meet the varying needs of ICPs, communication service providers, internet exchange service providers, enterprises, and other large-scale data center operators; DRX series of routers; and 8600 series of SDN-ready Internet Protocol/MPLS routers. Further, it provides transcend software suite; Infinera CNOS, a hardware-independent network operating system; and a range of support services for all hardware and software products. The company also serves telecommunications service providers, internet content providers, cable providers, wholesale carriers, research and education institutions, large enterprises, and government entities. It markets and sells its products and related support services primarily through its direct sales force. The company was formerly known as Zepton Networks. Infinera Corporation was founded in 2000 and is headquartered in Sunnyvale, California.", "industry_name": "Communications Equipment", "sector_name": "Information Technology", "is_defunct": false, "exchange": "NASDAQ", "equity_type": "stocks", "market_cap": 1112009784, "total_enterprise": 1444249784, "number_of_employees": 3261, "outstanding_shares": 183197658, "eps": -2.16007, "diluted_eps": -2.16007, "earnings_from_cont_operations": -386618000, "gross_profit": 416890000, "cash": 109201000, "total_debt": 441441000, "total_revenue": 1298865000, "cash_from_operations": -167350000, "net_income": -386618000, "ebitda": -91300000, "year_low_stock_price": 2.8, "year_high_stock_price": 8.35, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/INFN.png"}, {"symbol": "VREX", "name": "Varex Imaging Corporation", "next_earnings_utc": 1589313600, "next_earnings_has_time": true, "next_earnings_name": "2020 Q2", "next_earnings_year": 2020, "next_earnings_quarter": 2, "next_earnings_revenue_num_analysts": 5, "next_earnings_revenue_consensus": 199900000.0, "next_earnings_eps_num_analysts": 4, "next_earnings_eps_consensus": 0.34716, "eps_up_revisions": 0, "eps_down_revisions": 4, "revenue_up_revisions": 1, "revenue_down_revisions": 2, "total_analysts": 5, "analysts_sell": 0, "analysts_buy": 2, "analysts_outperform": 2, "analysts_hold": 1, "analysts_underperform": 0, "webpage": "vareximaging.com", "year_founded": null, "street_address": "1678 South Pioneer Road", "city": "Salt Lake City", "state": "UT", "zipcode": "84104", "country": "United States", "phone_number": "801-972-5000", "short_description": "Varex Imaging Corporation designs and manufactures X-ray imaging components.", "long_description": "Varex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, heat exchangers, ionization chambers, and buckys. This segment's products are used in a range of applications, including radiographic and fluoroscopic imaging, mammography, computed tomography, radiation therapy, oncology, cardiac, surgery, dental, and computer-aided detection. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital detectors, high voltage connectors, and image-processing software for use in security and industrial inspection applications, such as airport security, cargo screening at ports and borders, and nondestructive examination in various applications. Varex Imaging Corporation sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, Latin America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Varex Imaging Corporation is headquartered in Salt Lake City, Utah.", "industry_name": "Health Care Equipment and Supplies", "sector_name": "Health Care", "is_defunct": false, "exchange": "NASDAQ", "equity_type": "stocks", "market_cap": 997003639, "total_enterprise": 1389303639, "number_of_employees": 2000, "outstanding_shares": 38494349, "eps": 0.292428, "diluted_eps": 0.290323, "earnings_from_cont_operations": 11600000, "gross_profit": 261500000, "cash": 30000000, "total_debt": 408300000, "total_revenue": 795000000, "cash_from_operations": 74900000, "net_income": 11200000, "ebitda": 85100000, "year_low_stock_price": 16.4, "year_high_stock_price": 33.0, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/VREX.png"}, {"symbol": "HCAT", "name": "Health Catalyst, Inc.", "next_earnings_utc": 1589313900, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 6, "next_earnings_revenue_consensus": 44121500.0, "next_earnings_eps_num_analysts": 8, "next_earnings_eps_consensus": -0.25636, "eps_up_revisions": 1, "eps_down_revisions": 2, "revenue_up_revisions": 1, "revenue_down_revisions": 1, "total_analysts": 11, "analysts_sell": 0, "analysts_buy": 7, "analysts_outperform": 4, "analysts_hold": 0, "analysts_underperform": 0, "webpage": "healthcatalyst.com", "year_founded": 2008, "street_address": "3165 Millrock Drive", "city": "Salt Lake City", "state": "UT", "zipcode": "84121", "country": "United States", "phone_number": "855 309 6800", "short_description": "Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations primarily in the United States.", "long_description": "Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations primarily in the United States. The company operates through two segments, Technology and Professional services. Its products include cloud-based data platform, analytics software, and professional services. The company offers Data Operating System (DOS), a data platform that allows customers to integrate and organize their disparate data sources to enable analytics, including healthcare-specific terminology, data governance, and meta-data management. It also develops foundational software applications comprising Population Builder application that enables clinicians and administrators to author, manage, view, and publish pre-built and custom population ruleset definitions; Touchstone application for benchmarking solutions; and Leading Wisely application for dashboards and reporting solutions. In addition, the company provides domain-specific software applications, such as CORUS application for activity-based costing; patient safety monitor analytics; care management services; population health foundations solutions; and quality and regulatory measures solutions. Further, it offers analytics accelerators, which facilitate analytic insights across clinical, financial, and operational use-cases. Additionally, the company provides data and analytics services, including data engineering, analytic engineer, implementation, data science, analytics strategy, and data governance services; and clinical, financial, and operational services comprising quality and process improvement strategy, patient safety, cost accounting, population health and value-based care, abstraction data submission, and health catalyst university educational services. The company was founded in 2008 and is headquartered in Salt Lake City, Utah.", "industry_name": "Health Care Technology", "sector_name": "Health Care", "is_defunct": false, "exchange": "NASDAQ", "equity_type": "stocks", "market_cap": 1060551631, "total_enterprise": 884934631, "number_of_employees": 900, "outstanding_shares": 38094527, "eps": -12.855262, "diluted_eps": -12.855262, "earnings_from_cont_operations": -60096000, "gross_profit": 79704000, "cash": 228277000, "total_debt": 52660000, "total_revenue": 154941000, "cash_from_operations": -32184000, "net_income": -60096000, "ebitda": -45707000, "year_low_stock_price": 17.48, "year_high_stock_price": 49.85, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/HCAT.png"}, {"symbol": "GOSS", "name": "Gossamer Bio, Inc.", "next_earnings_utc": 1589313900, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 3, "next_earnings_revenue_consensus": 0.0, "next_earnings_eps_num_analysts": 1, "next_earnings_eps_consensus": -0.75, "eps_up_revisions": 0, "eps_down_revisions": 0, "revenue_up_revisions": 0, "revenue_down_revisions": 0, "total_analysts": 7, "analysts_sell": 0, "analysts_buy": 5, "analysts_outperform": 2, "analysts_hold": 0, "analysts_underperform": 0, "webpage": "gossamerbio.com", "year_founded": 2015, "street_address": "3013 Science Park Road", "city": "San Diego", "state": "CA", "zipcode": "92121", "country": "United States", "phone_number": "858 684 1300", "short_description": "Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States.", "long_description": "Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. It is developing GB001, an oral antagonist of prostaglandin D2 receptor 2, which is in Phase IIb clinical trial for the treatment of moderate-to-severe eosinophilic asthma; in Phase II clinical trial to treat patients with chronic rhinosinusitis both with and without nasal polyps; and in translational Phase 2 clinical trial in patients with chronic spontaneous urticarial. The company is also developing GB002, an orally inhaled, small molecule, selective platelet-derived growth factor receptor kinase inhibitor in Phase Ib clinical trial for the treatment of pulmonary arterial hypertension; GB004, a novel, gut-targeted, oral small molecule in Phase Ib clinical trial for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; and GB1275, an oral, small molecule, CD11b modulator in Phase 1/2 clinical trial for the treatment of selected solid tumor types. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and certain backup compounds; and Aerpio Pharmaceuticals, Inc. to develop and commercialize GB004 and related compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. Gossamer Bio, Inc. was founded in 2015 and is headquartered in San Diego, California.", "industry_name": "Biotechnology", "sector_name": "Health Care", "is_defunct": false, "exchange": "NASDAQ", "equity_type": "stocks", "market_cap": 989911070, "total_enterprise": 627632070, "number_of_employees": 171, "outstanding_shares": 66347927, "eps": -3.293869, "diluted_eps": -3.293869, "earnings_from_cont_operations": -180307000, "gross_profit": null, "cash": 401829000, "total_debt": 39550000, "total_revenue": null, "cash_from_operations": -144834000, "net_income": -180307000, "ebitda": -181622000, "year_low_stock_price": 7.52, "year_high_stock_price": 27.15, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/GOSS.png"}, {"symbol": "MAC", "name": "The Macerich Company", "next_earnings_utc": 1589281200, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 3, "next_earnings_revenue_consensus": 214956330.0, "next_earnings_eps_num_analysts": 4, "next_earnings_eps_consensus": 0.0025, "eps_up_revisions": 0, "eps_down_revisions": 1, "revenue_up_revisions": 0, "revenue_down_revisions": 0, "total_analysts": 18, "analysts_sell": 3, "analysts_buy": 3, "analysts_outperform": 0, "analysts_hold": 10, "analysts_underperform": 2, "webpage": "macerich.com", "year_founded": 1965, "street_address": "401 Wilshire Boulevard", "city": "Santa Monica", "state": "CA", "zipcode": "90401", "country": "United States", "phone_number": "310-394-6000", "short_description": "Macerich is a fully integrated, self-managed and self-administered real estate investment trust, which focuses on the acquisition, leasing, management, development and redevelopment of regional malls throughout the United States.", "long_description": "Macerich is a fully integrated, self-managed and self-administered real estate investment trust, which focuses on the acquisition, leasing, management, development and redevelopment of regional malls throughout the United States. Macerich currently owns 51 million square feet of real estate consisting primarily of interests in 47 regional shopping centers. Macerich specializes in successful retail properties in many of the country's most attractive, densely populated markets with significant presence in the West Coast, Arizona, Chicago and the Metro New York to Washington, DC corridor. A recognized leader in sustainability, Macerich has achieved the #1 GRESB ranking in the North American Retail Sector for five straight years (2015 - 2019).", "industry_name": "Equity Real Estate Investment Trusts (REITs)", "sector_name": "Real Estate", "is_defunct": false, "exchange": "NYSE", "equity_type": "stocks", "market_cap": 968099311, "total_enterprise": 6673930311, "number_of_employees": 730, "outstanding_shares": 141534987, "eps": 0.676595, "diluted_eps": 0.676595, "earnings_from_cont_operations": 102554000, "gross_profit": 608479000, "cash": 100005000, "total_debt": 5607128000, "total_revenue": 976432000, "cash_from_operations": 355157000, "net_income": 96820000, "ebitda": 597986000, "year_low_stock_price": 4.81, "year_high_stock_price": 42.8, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/MAC.png"}, {"symbol": "BTAI", "name": "BioXcel Therapeutics, Inc.", "next_earnings_utc": 1589281200, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 6, "next_earnings_revenue_consensus": 0.0, "next_earnings_eps_num_analysts": 5, "next_earnings_eps_consensus": -0.608, "eps_up_revisions": 0, "eps_down_revisions": 0, "revenue_up_revisions": 0, "revenue_down_revisions": 0, "total_analysts": 6, "analysts_sell": 0, "analysts_buy": 4, "analysts_outperform": 2, "analysts_hold": 0, "analysts_underperform": 0, "webpage": "bioxceltherapeutics.com", "year_founded": 2017, "street_address": "555 Long Wharf Drive", "city": "New Haven", "state": "CT", "zipcode": "06511", "country": "United States", "phone_number": "475 238 6837", "short_description": "BioXcel Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on novel artificial intelligence-based drug development in the fields of neuroscience and immuno-oncology in the United States.", "long_description": "BioXcel Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on novel artificial intelligence-based drug development in the fields of neuroscience and immuno-oncology in the United States. The company is involved in developing BXCL501, a sublingual thin film formulation of dexmedetomidine for acute treatment of agitation resulting from neurological and psychiatric disorders; and BXCL701, an immuno-oncology agent for the treatment of prostate and pancreatic cancers, and other solid tumors. BioXcel Therapeutics, Inc. has a collaboration with Merck KGaA; Nektar Therapeutics, Inc.; and Pfizer Inc. to develop a therapy for treating pancreatic cancer. The company was founded in 2017 and is headquartered in New Haven, Connecticut. BioXcel Therapeutics, Inc. is a subsidiary of BioXcel Corporation.", "industry_name": "Biotechnology", "sector_name": "Health Care", "is_defunct": false, "exchange": "NASDAQ", "equity_type": "stocks", "market_cap": 815570056, "total_enterprise": 784401056, "number_of_employees": 24, "outstanding_shares": 20182382, "eps": -2.02392, "diluted_eps": -2.02392, "earnings_from_cont_operations": -32968000, "gross_profit": null, "cash": 32426000, "total_debt": 1257000, "total_revenue": null, "cash_from_operations": -27280000, "net_income": -32968000, "ebitda": -33445000, "year_low_stock_price": 3.76, "year_high_stock_price": 43.63, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/BTAI.png"}, {"symbol": "CNR", "name": "Cornerstone Building Brands, Inc.", "next_earnings_utc": 1589314500, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 2, "next_earnings_revenue_consensus": 1103150000.0, "next_earnings_eps_num_analysts": 2, "next_earnings_eps_consensus": -0.265, "eps_up_revisions": 0, "eps_down_revisions": 2, "revenue_up_revisions": 1, "revenue_down_revisions": 0, "total_analysts": 3, "analysts_sell": 0, "analysts_buy": 0, "analysts_outperform": 1, "analysts_hold": 2, "analysts_underperform": 0, "webpage": "cornerstonebuildingbrands.com", "year_founded": 1984, "street_address": "5020 Weston Parkway", "city": "Cary", "state": "NC", "zipcode": "27513", "country": "United States", "phone_number": "866 419 0042", "short_description": "Cornerstone Building Brands, Inc., together with its subsidiaries, designs, engineers, manufactures, and markets external building products for the commercial, residential, and repair and remodel construction markets in North America.", "long_description": "Cornerstone Building Brands, Inc., together with its subsidiaries, designs, engineers, manufactures, and markets external building products for the commercial, residential, and repair and remodel construction markets in North America. The company operates through three segments: Commercial, Siding, and Windows. The Commercial segment manufactures and distributes various metal products for the nonresidential construction markets under various brand names through a network of plants and distribution centers. It also provides metal coil coating services for commercial and construction applications. The Siding segment offers vinyl siding and skirting products, steel siding products, vinyl and aluminum soffit products, aluminum trim coils, aluminum gutter coils, aluminum gutters, aluminum and steel roofing accessories, cellular PVC trims and moldings, J-channels, wide crown moldings, window and door trims, F-channels, H-molds, fascia, undersill trims, outside/inside corner posts, rain removal systems, and injection molded designer accents, such as shakes; shingles; scallops; shutters; vents and mounts; vinyl fence; vinyl railing; and stone veneer. The Windows segment provides vinyl, aluminum-clad vinyl, aluminum, wood, and clad-wood windows and patio doors; and steel, wood, and fiberglass entry doors. The company was formerly known as NCI Building Systems, Inc. and changed its name to Cornerstone Building Brands, Inc. in May 2019. Cornerstone Building Brands, Inc. was founded in 1984 and is headquartered in Cary, North Carolina.", "industry_name": "Building Products", "sector_name": "Industrials", "is_defunct": false, "exchange": "NYSE", "equity_type": "stocks", "market_cap": 628188718, "total_enterprise": 4058522718, "number_of_employees": 20100, "outstanding_shares": 126142313, "eps": -0.122555, "diluted_eps": -0.122555, "earnings_from_cont_operations": -15390000, "gross_profit": 1104668000, "cash": 98386000, "total_debt": 3528720000, "total_revenue": 4889747000, "cash_from_operations": 229608000, "net_income": -15390000, "ebitda": 562994000, "year_low_stock_price": 2.54, "year_high_stock_price": 9.79, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/CNR.png"}, {"symbol": "VEC", "name": "Vectrus, Inc.", "next_earnings_utc": 1589313900, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 3, "next_earnings_revenue_consensus": 337894670.0, "next_earnings_eps_num_analysts": 3, "next_earnings_eps_consensus": 0.74, "eps_up_revisions": 0, "eps_down_revisions": 2, "revenue_up_revisions": 0, "revenue_down_revisions": 2, "total_analysts": 3, "analysts_sell": 0, "analysts_buy": 3, "analysts_outperform": 0, "analysts_hold": 0, "analysts_underperform": 0, "webpage": "vectrus.com", "year_founded": 2014, "street_address": "2424 Garden of the Gods Road", "city": "Colorado Springs", "state": "CO", "zipcode": "80919", "country": "United States", "phone_number": "719 591 3600", "short_description": "Vectrus, Inc. provides facility and logistics, and information technology and network communication services to the United States (U.S.) government worldwide.", "long_description": "Vectrus, Inc. provides facility and logistics, and information technology and network communication services to the United States (U.S.) government worldwide. The company offers facility and logistics services, such as airfield management, ammunition management, civil engineering, communications, emergency services, life support activities, public works, security, transportation operations, warehouse management and distribution, and equipment maintenance, repair, and services. It also provides information technology and network communication services, including sustainment of communications systems, network security, systems installation, full life cycle management of information technology systems, system-of-systems engineering and software development, and mission support. In addition, the company offers operational technologies and converged solutions, such as sensor and systems integration, energy management, cybersecurity assessment and remediation planning for operational technology, electromagnetic spectrum engineering, energy resiliency and management, and integrated electronic security monitoring systems for military services and intelligence community, and foreign military sales and federal civilian agencies. Vectrus, Inc. was incorporated in 2014 and is headquartered in Colorado Springs, Colorado.", "industry_name": "Aerospace and Defense", "sector_name": "Industrials", "is_defunct": false, "exchange": "NYSE", "equity_type": "stocks", "market_cap": 558955143, "total_enterprise": 609418143, "number_of_employees": 7200, "outstanding_shares": 11586964, "eps": 3.033554, "diluted_eps": 2.99, "earnings_from_cont_operations": 34716000, "gross_profit": 129931000, "cash": 35318000, "total_debt": 85781000, "total_revenue": 1382642000, "cash_from_operations": 27557000, "net_income": 34716000, "ebitda": 59105000, "year_low_stock_price": 28.9, "year_high_stock_price": 59.24, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/VEC.png"}, {"symbol": "FI", "name": "Frank's International N.V.", "next_earnings_utc": 1589281200, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 4, "next_earnings_revenue_consensus": 134825000.0, "next_earnings_eps_num_analysts": 2, "next_earnings_eps_consensus": -0.04, "eps_up_revisions": 0, "eps_down_revisions": 1, "revenue_up_revisions": 0, "revenue_down_revisions": 2, "total_analysts": 7, "analysts_sell": 0, "analysts_buy": 1, "analysts_outperform": 1, "analysts_hold": 5, "analysts_underperform": 0, "webpage": "franksinternational.com", "year_founded": 1938, "street_address": "Mastenmakersweg 1", "city": "Den Helder", "state": null, "zipcode": "1786 PB", "country": "Netherlands", "phone_number": "31 22 367 0000", "short_description": "Frank's International N.V. provides various engineered tubular services for the oil and gas exploration and production, and oilfield services companies in the United States, Europe, the Middle East, Africa, Latin America, the Asia Pacific, and internationally.", "long_description": "Frank's International N.V. provides various engineered tubular services for the oil and gas exploration and production, and oilfield services companies in the United States, Europe, the Middle East, Africa, Latin America, the Asia Pacific, and internationally. It operates through three segments: Tubular Running Services, Tubulars, and Cementing Equipment. The company provides tubular running services; and specialized equipment, services, and products utilized in the construction, completion, and abandonment of the wellbore in onshore and offshore environments. Its tubular services include the handling and installation of multiple joints of pipe to establish a cased wellbore; and the installation of smaller diameter pipe inside a cased wellbore to provide a conduit for produced oil and gas to reach the surface. The company also designs, manufactures, and sells outside diameter (OD) pipes, connectors, and casing attachments; and provides specialized fabrication and welding services in support of deep water projects, including drilling and production risers, flowlines and pipeline end terminations, and long length tubulars for use as caissons or pilings. In addition, it offers specialty well construction and well intervention services and products; and distributes OD pipes manufactured by third parties. Frank's International N.V. was founded in 1938 and is headquartered in Den Helder, the Netherlands.", "industry_name": "Energy Equipment and Services", "sector_name": "Energy", "is_defunct": false, "exchange": "NYSE", "equity_type": "stocks", "market_cap": 483019014, "total_enterprise": 320530014, "number_of_employees": 3100, "outstanding_shares": 225709820, "eps": -1.045168, "diluted_eps": -1.05, "earnings_from_cont_operations": -235329000, "gross_profit": 162929000, "cash": 195383000, "total_debt": 32894000, "total_revenue": 579920000, "cash_from_operations": 27048000, "net_income": -235329000, "ebitda": 42485000, "year_low_stock_price": 1.66, "year_high_stock_price": 6.53, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/FI.png"}, {"symbol": "ALLT", "name": "Allot Ltd.", "next_earnings_utc": 1589274000, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 2, "next_earnings_revenue_consensus": 28978820.0, "next_earnings_eps_num_analysts": 3, "next_earnings_eps_consensus": -0.09, "eps_up_revisions": 1, "eps_down_revisions": 0, "revenue_up_revisions": 0, "revenue_down_revisions": 1, "total_analysts": 3, "analysts_sell": 0, "analysts_buy": 2, "analysts_outperform": 1, "analysts_hold": 0, "analysts_underperform": 0, "webpage": "allot.com", "year_founded": 1996, "street_address": "22 Hanagar Street", "city": "Hod HaSharon", "state": null, "zipcode": "4501317", "country": "Israel", "phone_number": "972 9 761 9200", "short_description": "Allot Ltd. provides network intelligence and security solutions to protect and personalize the digital experience worldwide.", "long_description": "Allot Ltd. provides network intelligence and security solutions to protect and personalize the digital experience worldwide. It offers various platforms, including Allot Service Gateway 9500 and 9700, Allot Service Gateway Tera, Allot Service Gateway Virtual Edition, and Allot Secure Service Gateway, for in-line deployment in traditional and virtualized network access infrastructure. The company also provides subscriber management platform that drives the centralized creation, provisioning, and pricing of subscriber services; and analytics solutions comprising Allot ClearSee Analytics and Allot ClearSee Data Source that analyze traffic data. In addition, it offers security solutions comprising Allot NetworkSecure, Allot HomeSecure, Allot IoTSecure, Allot DDoS Secure, Allot Content Protector, Allot SpamOut Protector, and Allot Unified Security, as well as security as a service for protecting network service integrity and brand reputation. Further, the company offers centralized management solutions, such as Allot NetXplorer for providing a central access point for network-wide monitoring, reporting, analytics, troubleshooting, accounting, and quality of service policy provisioning. It markets its products through direct sales, distributors, resellers, original equipment manufacturers, and system integrators to carriers, mobile and fixed service providers, cable operators, private networks, data centers, educational institutions, governments, and enterprises, as well as wireless, wireline, and satellite Internet service providers. The company was formerly known as Allot Communications Ltd. and changed its name to Allot Ltd. in October 2018. Allot Ltd. was founded in 1996 and is based in Hod-Hasharon, Israel.", "industry_name": "Software", "sector_name": "Information Technology", "is_defunct": false, "exchange": "NASDAQ", "equity_type": "stocks", "market_cap": 412243199, "total_enterprise": 335715199, "number_of_employees": 493, "outstanding_shares": 34700606, "eps": -0.252813, "diluted_eps": -0.252813, "earnings_from_cont_operations": -8659000, "gross_profit": 76266000, "cash": 83499000, "total_debt": 6971000, "total_revenue": 110100000, "cash_from_operations": 16092000, "net_income": -8659000, "ebitda": -4924000, "year_low_stock_price": 6.44, "year_high_stock_price": 13.05, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/ALLT.png"}, {"symbol": "TUFN", "name": "Tufin Software Technologies Ltd.", "next_earnings_utc": 1589283900, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 6, "next_earnings_revenue_consensus": 21120170.0, "next_earnings_eps_num_analysts": 9, "next_earnings_eps_consensus": -0.40156, "eps_up_revisions": 0, "eps_down_revisions": 7, "revenue_up_revisions": 0, "revenue_down_revisions": 5, "total_analysts": 9, "analysts_sell": 0, "analysts_buy": 2, "analysts_outperform": 3, "analysts_hold": 4, "analysts_underperform": 0, "webpage": "tufin.com", "year_founded": 2005, "street_address": "5 HaShalom Road", "city": "Tel Aviv", "state": null, "zipcode": "6789205", "country": "Israel", "phone_number": "972 3 612 8118", "short_description": "Tufin Software Technologies Ltd. develops, markets, and sells software-based solutions primarily in the United States, Europe, and Asia.", "long_description": "Tufin Software Technologies Ltd. develops, markets, and sells software-based solutions primarily in the United States, Europe, and Asia. It offers SecureTrack, SecureChange, and SecureApp products that enable enterprises to visualize, define, and enforce their security policy across heterogeneous networks, on premise and in the cloud. The company also provides Orca and Iris products, which provide cloud-based security automation solutions in response to the growth of containers and cloud-native environments. Tufin Software Technologies sells its products and services through sales force, distributors, and resellers, as well as service delivery partners. The company was founded in 2005 and is headquartered in Tel Aviv, Israel.", "industry_name": "Software", "sector_name": "Information Technology", "is_defunct": false, "exchange": "NYSE", "equity_type": "stocks", "market_cap": 361746946, "total_enterprise": 267618946, "number_of_employees": 568, "outstanding_shares": 35500191, "eps": -1.03805, "diluted_eps": -1.03805, "earnings_from_cont_operations": -28119000, "gross_profit": 83413000, "cash": 118661000, "total_debt": 24533000, "total_revenue": 103270000, "cash_from_operations": -9621000, "net_income": -28119000, "ebitda": -25818000, "year_low_stock_price": 5.79, "year_high_stock_price": 31.04, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/TUFN.png"}, {"symbol": "CCAP", "name": "Crescent Capital BDC, Inc.", "next_earnings_utc": 1589313600, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 1, "next_earnings_revenue_consensus": 15590000.0, "next_earnings_eps_num_analysts": 1, "next_earnings_eps_consensus": 0.4, "eps_up_revisions": 0, "eps_down_revisions": 1, "revenue_up_revisions": 0, "revenue_down_revisions": 1, "total_analysts": 1, "analysts_sell": 0, "analysts_buy": 0, "analysts_outperform": 1, "analysts_hold": 0, "analysts_underperform": 0, "webpage": "crescentbdc.com", "year_founded": null, "street_address": null, "city": null, "state": null, "zipcode": null, "country": null, "phone_number": null, "short_description": null, "long_description": null, "industry_name": "Capital Markets", "sector_name": "Financials", "is_defunct": false, "exchange": "NASDAQ", "equity_type": "stocks", "market_cap": 319440528, "total_enterprise": 636874348, "number_of_employees": null, "outstanding_shares": 28219128, "eps": 1.688044, "diluted_eps": 1.688044, "earnings_from_cont_operations": 29278523, "gross_profit": 53476763, "cash": 4576234, "total_debt": 322010054, "total_revenue": 53476763, "cash_from_operations": -202985537, "net_income": 29278523, "ebitda": null, "year_low_stock_price": 6.21, "year_high_stock_price": 17.99, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/CCAP.png"}, {"symbol": "CELH", "name": "Celsius Holdings, Inc.", "next_earnings_utc": 1589286600, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 4, "next_earnings_revenue_consensus": 23358980.0, "next_earnings_eps_num_analysts": 4, "next_earnings_eps_consensus": -0.0075, "eps_up_revisions": 1, "eps_down_revisions": 0, "revenue_up_revisions": 1, "revenue_down_revisions": 1, "total_analysts": 4, "analysts_sell": 0, "analysts_buy": 2, "analysts_outperform": 2, "analysts_hold": 0, "analysts_underperform": 0, "webpage": "celsiusholdingsinc.com", "year_founded": 2004, "street_address": "2424 North Federal Highway", "city": "Boca Raton", "state": "FL", "zipcode": "33431", "country": "United States", "phone_number": "561 276 2239", "short_description": "Celsius Holdings, Inc. develops, markets, distributes, and sells functional calorie-burning fitness beverages in the United States and internationally.", "long_description": "Celsius Holdings, Inc. develops, markets, distributes, and sells functional calorie-burning fitness beverages in the United States and internationally. The company offers its beverages in various flavors, including carbonated orange, wild berry, cola, grape, kiwi-guava, and watermelon; and non-carbonated green tea raspberry/acai, green tea/peach mango, pineapple coconut, watermelon berry, and strawberries and cream, as well as sparkling grapefruit, cucumber lime, and orange pomegranate under the Celsius brand name. It also provides Celsius Heat, a dietary supplement in carbonated flavors, such as apple jack'd, orangesicle, inferno punch, cherry lime, blueberry pomegranate, strawberry dragonfruit, and tangerine grapefruit. The company distributes its products through direct-store delivery distributors, as well as directly to retailers across various retail segments comprising supermarkets, convenience stores, drug stores, nutritional stores, and mass merchants, as well as health clubs, spas, gyms, the military, and e-commerce Websites. The company was formerly known as Vector Ventures, Inc. and changed its name to Celsius Holdings, Inc. in January 2007. Celsius Holdings, Inc. was founded in 2004 and is based in Boca Raton, Florida.", "industry_name": "Beverages", "sector_name": "Consumer Staples", "is_defunct": false, "exchange": "NASDAQ", "equity_type": "stocks", "market_cap": 352427833, "total_enterprise": 338860352, "number_of_employees": 120, "outstanding_shares": 69239260, "eps": 0.164103, "diluted_eps": 0.164103, "earnings_from_cont_operations": 9971260, "gross_profit": 31301813, "cash": 23090682, "total_debt": 9523201, "total_revenue": 75146546, "cash_from_operations": 1033988, "net_income": 9971260, "ebitda": 24970, "year_low_stock_price": 3.06, "year_high_stock_price": 7.1, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/CELH.png"}, {"symbol": "BIOX", "name": "Bioceres Crop Solutions Corp.", "next_earnings_utc": 1589256000, "next_earnings_has_time": true, "next_earnings_name": "2020 Q3", "next_earnings_year": 2020, "next_earnings_quarter": 3, "next_earnings_revenue_num_analysts": 2, "next_earnings_revenue_consensus": 20000000.0, "next_earnings_eps_num_analysts": 2, "next_earnings_eps_consensus": -0.115, "eps_up_revisions": 0, "eps_down_revisions": 1, "revenue_up_revisions": 0, "revenue_down_revisions": 2, "total_analysts": 2, "analysts_sell": 0, "analysts_buy": 2, "analysts_outperform": 0, "analysts_hold": 0, "analysts_underperform": 0, "webpage": "biocerescrops.com", "year_founded": null, "street_address": "Ocampo 210 bis", "city": "Rosario", "state": null, "zipcode": "2000", "country": "Argentina", "phone_number": "54 34 1486 1100", "short_description": "Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions.", "long_description": "Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. The company operates in three segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment develops and commercializes seed technology, biotechnological events, germplasm, and seed treatments. The Crop Protection segment develops, produces, and markets adjuvants, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. In addition, the company offers HB4, a drought tolerant seed technology program. It serves clients in Argentina, Austria, Bolivia, Brazil, China, Libano, the United States, Italy, Paraguay, the United Kingdom, South Africa, France, Canada, Ukraine, Uruguay, and internationally. The company is headquartered in Rosario, Argentina. Bioceres Crop Solutions Corp. is a subsidiary of Bioceres S.A.", "industry_name": "Food Products", "sector_name": "Consumer Staples", "is_defunct": false, "exchange": "NYSEMKT", "equity_type": "stocks", "market_cap": 211305024, "total_enterprise": 326764231, "number_of_employees": 389, "outstanding_shares": 36120517, "eps": -0.601526, "diluted_eps": -0.601601, "earnings_from_cont_operations": -19253363, "gross_profit": 74433648, "cash": 11218057, "total_debt": 112351387, "total_revenue": 166752840, "cash_from_operations": 37876371, "net_income": -18333547, "ebitda": 33515745, "year_low_stock_price": 4.01, "year_high_stock_price": 7.65, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/BIOX.png"}, {"symbol": "CRHM", "name": "CRH Medical Corporation", "next_earnings_utc": 1589317200, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 4, "next_earnings_revenue_consensus": 27561500.0, "next_earnings_eps_num_analysts": 1, "next_earnings_eps_consensus": 0.0, "eps_up_revisions": 0, "eps_down_revisions": 1, "revenue_up_revisions": 0, "revenue_down_revisions": 2, "total_analysts": 7, "analysts_sell": 0, "analysts_buy": 5, "analysts_outperform": 2, "analysts_hold": 0, "analysts_underperform": 0, "webpage": "crhsystem.com", "year_founded": 2000, "street_address": "World Trade Center", "city": "Vancouver", "state": "BC", "zipcode": "V6C 3E1", "country": "Canada", "phone_number": "800-660-2153", "short_description": "CRH Medical Corporation provides various products and services to gastroenterologists in the United States and Canada.", "long_description": "CRH Medical Corporation provides various products and services to gastroenterologists in the United States and Canada. It offers CRH O\u2019Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid. The company also offers anesthesia services for patients undergoing endoscopic procedures. It distributes the CRH O\u2019Regan system, treatment protocols, and operational and marketing expertise as a turnkey package directly to physicians. The company was formerly known as Medsurge Medical Products Corp. and changed its name to CRH Medical Corporation in April 2006. CRH Medical Corporation was founded in 2000 and is headquartered in Vancouver, Canada.", "industry_name": "Health Care Providers and Services", "sector_name": "Health Care", "is_defunct": false, "exchange": "NYSEMKT", "equity_type": "stocks", "market_cap": 146988630, "total_enterprise": 249404089, "number_of_employees": 152, "outstanding_shares": 71573184, "eps": 0.052716, "diluted_eps": 0.051999, "earnings_from_cont_operations": 8212484, "gross_profit": 21579619, "cash": 6568716, "total_debt": 68628800, "total_revenue": 120385274, "cash_from_operations": 45005557, "net_income": 3771163, "ebitda": 50726265, "year_low_stock_price": 0.8599, "year_high_stock_price": 4.43, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/CRHM.png"}, {"symbol": "TELA", "name": "TELA Bio, Inc.", "next_earnings_utc": 1589313600, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 4, "next_earnings_revenue_consensus": 3666750.0, "next_earnings_eps_num_analysts": 4, "next_earnings_eps_consensus": -0.565, "eps_up_revisions": 2, "eps_down_revisions": 2, "revenue_up_revisions": 0, "revenue_down_revisions": 4, "total_analysts": 4, "analysts_sell": 0, "analysts_buy": 2, "analysts_outperform": 2, "analysts_hold": 0, "analysts_underperform": 0, "webpage": "telabio.com", "year_founded": 2012, "street_address": "1 Great Valley Parkway", "city": "Malvern", "state": "PA", "zipcode": "19355", "country": "United States", "phone_number": "484 320 2930", "short_description": "TELA Bio, Inc., a medical technology company, focuses on the design, development, and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction.", "long_description": "TELA Bio, Inc., a medical technology company, focuses on the design, development, and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was founded in 2012 and is headquartered in Malvern, Pennsylvania.", "industry_name": "Health Care Equipment and Supplies", "sector_name": "Health Care", "is_defunct": false, "exchange": "NASDAQ", "equity_type": "stocks", "market_cap": 135405434, "total_enterprise": 111278434, "number_of_employees": 89, "outstanding_shares": 11407366, "eps": -17.101371, "diluted_eps": -17.101371, "earnings_from_cont_operations": -22425000, "gross_profit": 9576000, "cash": 54587000, "total_debt": 30460000, "total_revenue": 15446000, "cash_from_operations": -25523000, "net_income": -22425000, "ebitda": -18580000, "year_low_stock_price": 5.25, "year_high_stock_price": 18.88, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/TELA.png"}, {"symbol": "CMBM", "name": "Cambium Networks Corporation", "next_earnings_utc": 1589313600, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 5, "next_earnings_revenue_consensus": 55719200.0, "next_earnings_eps_num_analysts": 5, "next_earnings_eps_consensus": -0.02375, "eps_up_revisions": 0, "eps_down_revisions": 4, "revenue_up_revisions": 0, "revenue_down_revisions": 4, "total_analysts": 5, "analysts_sell": 0, "analysts_buy": 1, "analysts_outperform": 2, "analysts_hold": 2, "analysts_underperform": 0, "webpage": "cambiumnetworks.com", "year_founded": 2011, "street_address": "3800 Golf Road", "city": "Rolling Meadows", "state": "IL", "zipcode": "60008", "country": "United States", "phone_number": "888 863 5250", "short_description": "Cambium Networks Corporation, through its subsidiaries, provides wireless broadband networking infrastructure products and solutions for network operators.", "long_description": "Cambium Networks Corporation, through its subsidiaries, provides wireless broadband networking infrastructure products and solutions for network operators. Its wireless fabric includes intelligent radios, smart antennas, radio frequency (RF) algorithms, wireless-aware switches, and network management software. The company offers point-to-point solutions that are connected to high-speed, high-bandwidth wireline networks; and wireless broadband backhaul to facilities or point-to-multipoint access points deployed throughout a network over distances of approximately 100 kilometers and at 2 gigabytes per second. Its cnPilot and Xirrus Wi-Fi solution provides distributed access to individual users in indoor settings, such as office complexes, and outdoor settings, such as athletic stadiums; cnReach solutions offer narrow-band connectivity for sensors and devices; embedded proprietary RF technology and software enables automated optimization of data flow at the outermost points in the network; and cnMatrix cloud-managed wireless-aware switching solution provides the interface between wireless and wired networks. The company serves medium-sized wireless Internet service providers, enterprises, and government agencies in North America, Europe, the Middle East, Africa, Central and Latin America, and the Asia-Pacific. The company was formerly known as Vector Cambium Holdings (Cayman), Ltd. and changed its name to Cambium Networks Corporation in 2018. Cambium Networks Corporation was founded in 2011 and is headquartered in Rolling Meadows, Illinois.", "industry_name": "Communications Equipment", "sector_name": "Information Technology", "is_defunct": false, "exchange": "NASDAQ", "equity_type": "stocks", "market_cap": 143552776, "total_enterprise": 195278776, "number_of_employees": 533, "outstanding_shares": 25680282, "eps": -0.891561, "diluted_eps": -0.891561, "earnings_from_cont_operations": -17601000, "gross_profit": 131440000, "cash": 19346000, "total_debt": 71072000, "total_revenue": 267028000, "cash_from_operations": 3553000, "net_income": -17601000, "ebitda": 24164000, "year_low_stock_price": 3.6, "year_high_stock_price": 11.75, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/CMBM.png"}, {"symbol": "ELMD", "name": "Electromed, Inc.", "next_earnings_utc": 1589315400, "next_earnings_has_time": true, "next_earnings_name": "2020 Q3", "next_earnings_year": 2020, "next_earnings_quarter": 3, "next_earnings_revenue_num_analysts": 1, "next_earnings_revenue_consensus": 8593000.0, "next_earnings_eps_num_analysts": 1, "next_earnings_eps_consensus": 0.06, "eps_up_revisions": 0, "eps_down_revisions": 0, "revenue_up_revisions": 1, "revenue_down_revisions": 0, "total_analysts": 1, "analysts_sell": 0, "analysts_buy": 0, "analysts_outperform": 1, "analysts_hold": 0, "analysts_underperform": 0, "webpage": "smartvest.com", "year_founded": 1992, "street_address": "500 Sixth Avenue NW", "city": "New Prague", "state": "MN", "zipcode": "56071", "country": "United States", "phone_number": "952 758 9299", "short_description": "Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation therapy in pulmonary care for patients of all ages in the United States and internationally.", "long_description": "Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation therapy in pulmonary care for patients of all ages in the United States and internationally. The company offers SmartVest airway clearance system that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to patients with compromised pulmonary function; and SmartVest SQL System that provides advanced generator programmability and an enhanced pause feature with save, lock, and restore functionality. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers working in intensive care units; and Aerobika, an oscillating positive expiratory pressure device. The company offers its products primarily to home health care market for patients with chronic lung issues, including bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was founded in 1992 and is headquartered in New Prague, Minnesota.", "industry_name": "Health Care Equipment and Supplies", "sector_name": "Health Care", "is_defunct": false, "exchange": "NYSEMKT", "equity_type": "stocks", "market_cap": 131500728, "total_enterprise": 122416572, "number_of_employees": 119, "outstanding_shares": 8478448, "eps": 0.4344, "diluted_eps": 0.420774, "earnings_from_cont_operations": 3631151, "gross_profit": 25260469, "cash": 9206722, "total_debt": 122566, "total_revenue": 32860820, "cash_from_operations": 3792884, "net_income": 3631151, "ebitda": 5777008, "year_low_stock_price": 4.75, "year_high_stock_price": 19.73, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/ELMD.png"}, {"symbol": "CATB", "name": "Catabasis Pharmaceuticals, Inc.", "next_earnings_utc": 1589314200, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 2, "next_earnings_revenue_consensus": 0.0, "next_earnings_eps_num_analysts": 2, "next_earnings_eps_consensus": -0.41, "eps_up_revisions": 1, "eps_down_revisions": 0, "revenue_up_revisions": 0, "revenue_down_revisions": 0, "total_analysts": 2, "analysts_sell": 0, "analysts_buy": 2, "analysts_outperform": 0, "analysts_hold": 0, "analysts_underperform": 0, "webpage": "catabasis.com", "year_founded": 2008, "street_address": "Building 1400E", "city": "Cambridge", "state": "MA", "zipcode": "02139", "country": "United States", "phone_number": "617-349-1971", "short_description": "Catabasis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics based on safely metabolized and rationally targeted (SMART) linker drug discovery platform in the United States.", "long_description": "Catabasis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics based on safely metabolized and rationally targeted (SMART) linker drug discovery platform in the United States. The company\u00e2\u20ac\u2122s lead product candidate is Edasalonexent, an oral small molecule that inhibits nuclear factor kappa-light-chain-enhancer of activate B cells, which is in Phase III clinical trial for the treatment of duchenne muscular dystrophy (DMD). It is also involved in developing CAT-5571 for the treatment of cystic fibrosis. Catabasis Pharmaceuticals, Inc. has a pre-clinical joint research collaboration agreement with Sarepta Therapeutics, Inc. to explore a combination drug treatment approach for DMD; and collaboration with the University of Texas Southwestern to study the potential benefits of edasalonexent treatment. The company also has a preclinical research collaboration with the Jain Foundation to study edasalonexent (CAT-1004) in Dysferlinopathy. The company was founded in 2008 and is based in Cambridge, Massachusetts.", "industry_name": "Biotechnology", "sector_name": "Health Care", "is_defunct": false, "exchange": "NASDAQ", "equity_type": "stocks", "market_cap": 108456862, "total_enterprise": 74465862, "number_of_employees": 27, "outstanding_shares": 17897172, "eps": -2.347786, "diluted_eps": -2.347786, "earnings_from_cont_operations": -26293000, "gross_profit": null, "cash": 36244000, "total_debt": 2253000, "total_revenue": 250000, "cash_from_operations": -26569000, "net_income": -26293000, "ebitda": -27062000, "year_low_stock_price": 2.74, "year_high_stock_price": 8.9, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/CATB.png"}, {"symbol": "PTN", "name": "Palatin Technologies, Inc.", "next_earnings_utc": 1589283000, "next_earnings_has_time": true, "next_earnings_name": "2020 Q3", "next_earnings_year": 2020, "next_earnings_quarter": 3, "next_earnings_revenue_num_analysts": 2, "next_earnings_revenue_consensus": 56500.0, "next_earnings_eps_num_analysts": 3, "next_earnings_eps_consensus": -0.02, "eps_up_revisions": 0, "eps_down_revisions": 1, "revenue_up_revisions": 0, "revenue_down_revisions": 1, "total_analysts": 3, "analysts_sell": 0, "analysts_buy": 2, "analysts_outperform": 1, "analysts_hold": 0, "analysts_underperform": 0, "webpage": "palatin.com", "year_founded": 1986, "street_address": "Cedar Brook Corporate Center", "city": "Cranbury", "state": "NJ", "zipcode": "08512", "country": "United States", "phone_number": "609-495-2200", "short_description": "Palatin Technologies, Inc., a specialized biopharmaceutical company, develops targeted receptor-specific product candidates for the treatment of various diseases in the United States.", "long_description": "Palatin Technologies, Inc., a specialized biopharmaceutical company, develops targeted receptor-specific product candidates for the treatment of various diseases in the United States. The company\u00e2\u20ac\u2122s lead product is Vyleesi, a melanocortin receptor agonist, which has completed Phase III trial for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder. It is also developing oral PL8177, a selective melanocortin receptor 1 (MCr) agonist peptide that has completed Phase I clinical trial for inflammatory bowel diseases; and systemic PL8177, which has completed Phase I clinical trial for treating non-infectious uveitis. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease. Further, it is involved in developing MC4r agonist peptide and small molecule for the treatment of rare genetic metabolic and obesity disorders. Additionally, the company engages in the development of PL3994, a natriuretic peptide receptor (NPR)-A agonist and synthetic mimetic of the endogenous neuropeptide hormone atrial natriuretic peptide for cardiovascular indications; and PL5028, a dual NPR-A and NPR-C agonist to treat cardiovascular and fibrotic diseases, including reducing cardiac hypertrophy and fibrosis. Palatin Technologies, Inc. was founded in 1986 and is based in Cranbury, New Jersey.", "industry_name": "Biotechnology", "sector_name": "Health Care", "is_defunct": false, "exchange": "NYSEMKT", "equity_type": "stocks", "market_cap": 104518904, "total_enterprise": 13233130, "number_of_employees": 18, "outstanding_shares": 229258400, "eps": 0.165689, "diluted_eps": 0.154449, "earnings_from_cont_operations": 36752857, "gross_profit": 45726099, "cash": 91459480, "total_debt": 173666, "total_revenue": 60383960, "cash_from_operations": 39161115, "net_income": 36752857, "ebitda": 35986909, "year_low_stock_price": 0.355, "year_high_stock_price": 1.78, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/PTN.png"}, {"symbol": "TCS", "name": "The Container Store Group, Inc.", "next_earnings_utc": 1589313900, "next_earnings_has_time": true, "next_earnings_name": "2020 Q4", "next_earnings_year": 2020, "next_earnings_quarter": 4, "next_earnings_revenue_num_analysts": 3, "next_earnings_revenue_consensus": 249949670.0, "next_earnings_eps_num_analysts": 3, "next_earnings_eps_consensus": 0.34781, "eps_up_revisions": 1, "eps_down_revisions": 1, "revenue_up_revisions": 0, "revenue_down_revisions": 0, "total_analysts": 3, "analysts_sell": 0, "analysts_buy": 0, "analysts_outperform": 0, "analysts_hold": 2, "analysts_underperform": 1, "webpage": "containerstore.com", "year_founded": 1978, "street_address": "500 Freeport Parkway", "city": "Coppell", "state": "TX", "zipcode": "75019", "country": "United States", "phone_number": "972-538-6000", "short_description": "The Container Store Group, Inc. operates as a retailer of storage and organization products and solutions in the United States.", "long_description": "The Container Store Group, Inc. operates as a retailer of storage and organization products and solutions in the United States. It operates in two segments, The Container Store and Elfa. The company offers approximately 10,000 products designed to help customers. Its merchandise category includes Custom Closets, including elfa and Laren branded products and installation services, as well as closet lifestyle department products; storage, long-term storage, and shelving; kitchen and trash; office, collections, and hooks; bath, travel, and laundry; gift packaging, seasonal, and impulse; and others. The company also designs, manufactures, and sells component-based shelving and drawer systems that are customizable for any area of the home, such as closets, kitchens, offices, and garages, as well as made-to-measure sliding doors. As of March 30, 2019, it operated 92 stores with an average size of approximately 25,000 square feet in 33 states and the District of Columbia. The company also operates a custom closet store; and offers its products directly to customers through its Website, responsive mobile site, and call center, as well as sells to various retailers and distributors, and on a wholesale basis. The Container Store Group, Inc. was founded in 1978 and is headquartered in Coppell, Texas.", "industry_name": "Specialty Retail", "sector_name": "Consumer Discretionary", "is_defunct": false, "exchange": "NYSE", "equity_type": "stocks", "market_cap": 112559306, "total_enterprise": 787998306, "number_of_employees": 3660, "outstanding_shares": 49368117, "eps": 0.365772, "diluted_eps": 0.365772, "earnings_from_cont_operations": 17841000, "gross_profit": 539256000, "cash": 13971000, "total_debt": 689410000, "total_revenue": 927789000, "cash_from_operations": 35937000, "net_income": 17841000, "ebitda": 80691000, "year_low_stock_price": 1.8, "year_high_stock_price": 9.5, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/TCS.png"}, {"symbol": "RDCM", "name": "RADCOM Ltd.", "next_earnings_utc": 1589281200, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 2, "next_earnings_revenue_consensus": 8014500.0, "next_earnings_eps_num_analysts": 1, "next_earnings_eps_consensus": -0.12, "eps_up_revisions": 0, "eps_down_revisions": 1, "revenue_up_revisions": 0, "revenue_down_revisions": 1, "total_analysts": 2, "analysts_sell": 0, "analysts_buy": 1, "analysts_outperform": 0, "analysts_hold": 1, "analysts_underperform": 0, "webpage": "radcom.com", "year_founded": 1985, "street_address": "24 Raoul Wallenberg Street", "city": "Tel Aviv", "state": null, "zipcode": "69719", "country": "Israel", "phone_number": "972 3 645 5055", "short_description": "RADCOM Ltd. provides service assurance and customer experience management solutions for communication service providers (CSPs). Its carrier-grade solutions support mobile and fixed networks, and scale to terabit data bandwidths to enable data analytics.", "long_description": "RADCOM Ltd. provides service assurance and customer experience management solutions for communication service providers (CSPs). Its carrier-grade solutions support mobile and fixed networks, and scale to terabit data bandwidths to enable data analytics. The company offers solutions for virtualized infrastructure and next-generation networks. Its product line includes the RADCOM Service Assurance, a next-generation probe-based customer and service assurance solution that enables CSPs to carry out end-to-end data and voice quality monitoring, manage their networks and services, and monitor their roaming and interconnect traffic. The company\u00e2\u20ac\u2122s RADCOM Service Assurance solution also provides service assurance monitoring applications, including network troubleshooting and quality monitoring, service quality monitoring, customer quality of service monitoring, and customer service level agreements monitoring. In addition, it offers RADCOM Network Visibility, an automated network function virtualization orchestration solution for onboarding and configuration that enables traffic distribution, load balancing, and end-to-end visibility across virtual networks, as well as provides packet broker capabilities, like packet de-duplication, secure socket layer decryption, and packet slicing. Further, it provides RADCOM Network Insights, which offers CSPs with real-time actionable business and marketing insights. The company sells its products directly, as well as through a network of independent distributors and resellers worldwide. The company was formerly known as Big Blue Catalogue Ltd. and changed its name to RADCOM Ltd. in 1989. RADCOM Ltd. was founded in 1985 and is headquartered in Tel Aviv, Israel.", "industry_name": "Communications Equipment", "sector_name": "Information Technology", "is_defunct": false, "exchange": "NASDAQ", "equity_type": "stocks", "market_cap": 97184766, "total_enterprise": 34133766, "number_of_employees": 282, "outstanding_shares": 13883538, "eps": -0.495795, "diluted_eps": -0.5, "earnings_from_cont_operations": -6832000, "gross_profit": 23093000, "cash": 69281000, "total_debt": 6230000, "total_revenue": 33010000, "cash_from_operations": 6840000, "net_income": -6832000, "ebitda": -7083000, "year_low_stock_price": 5.23, "year_high_stock_price": 10.37, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/RDCM.png"}, {"symbol": "METC", "name": "Ramaco Resources, Inc.", "next_earnings_utc": 1589317200, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 3, "next_earnings_revenue_consensus": 41962000.0, "next_earnings_eps_num_analysts": 4, "next_earnings_eps_consensus": 0.04, "eps_up_revisions": 0, "eps_down_revisions": 1, "revenue_up_revisions": null, "revenue_down_revisions": null, "total_analysts": 6, "analysts_sell": 0, "analysts_buy": 3, "analysts_outperform": 2, "analysts_hold": 1, "analysts_underperform": 0, "webpage": "ramacoresources.com", "year_founded": 2015, "street_address": "250 West Main Street", "city": "Lexington", "state": "KY", "zipcode": "40507", "country": "United States", "phone_number": "859-244-7455", "short_description": "Ramaco Resources, Inc. produces and sells metallurgical coal The company's development portfolio includes the Elk Creek project consisting of approximately 20,552 acres of controlled mineral and 24 seams located in southern West Virginia; the Berwind coal property comprising approximately 31,200 acres of controlled mineral and an area of Squire Jim seam coal deposits, which is situated on the border of West Virginia and Virginia; the Knox Creek property consisting of approximately 61,343 acres of controlled mineral that is located in Virginia; and the RAM Mine property comprising approximately 1,567 acres of controlled mineral, which is situated in southwestern Pennsylvania.", "long_description": "Ramaco Resources, Inc. produces and sells metallurgical coal The company's development portfolio includes the Elk Creek project consisting of approximately 20,552 acres of controlled mineral and 24 seams located in southern West Virginia; the Berwind coal property comprising approximately 31,200 acres of controlled mineral and an area of Squire Jim seam coal deposits, which is situated on the border of West Virginia and Virginia; the Knox Creek property consisting of approximately 61,343 acres of controlled mineral that is located in Virginia; and the RAM Mine property comprising approximately 1,567 acres of controlled mineral, which is situated in southwestern Pennsylvania. The company serves blast furnace steel mills and coke plants in the United States, as well as international metallurgical coal consumers. The company was founded in 2015 and is headquartered in Lexington, Kentucky.", "industry_name": "Metals and Mining", "sector_name": "Materials", "is_defunct": false, "exchange": "NASDAQ", "equity_type": "stocks", "market_cap": 87562361, "total_enterprise": 95177361, "number_of_employees": 395, "outstanding_shares": 42713347, "eps": 0.610558, "diluted_eps": 0.61, "earnings_from_cont_operations": 24934000, "gross_profit": 67743000, "cash": 5532000, "total_debt": 13147000, "total_revenue": 230213000, "cash_from_operations": 42382000, "net_income": 24934000, "ebitda": 49564000, "year_low_stock_price": 2.0, "year_high_stock_price": 6.95, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/METC.png"}, {"symbol": "GSL", "name": "Global Ship Lease, Inc.", "next_earnings_utc": 1589287500, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 1, "next_earnings_revenue_consensus": 71109000.0, "next_earnings_eps_num_analysts": 1, "next_earnings_eps_consensus": 0.41, "eps_up_revisions": 1, "eps_down_revisions": 0, "revenue_up_revisions": 1, "revenue_down_revisions": 0, "total_analysts": 2, "analysts_sell": 0, "analysts_buy": 2, "analysts_outperform": 0, "analysts_hold": 0, "analysts_underperform": 0, "webpage": "globalshiplease.com", "year_founded": null, "street_address": "25 Wilton Road", "city": "London", "state": null, "zipcode": "SW1V 1LW", "country": "United Kingdom", "phone_number": "44 20 3998 0063", "short_description": "Global Ship Lease, Inc. owns and charters containerships of various sizes under fixed-rate charters to container shipping companies.", "long_description": "Global Ship Lease, Inc. owns and charters containerships of various sizes under fixed-rate charters to container shipping companies. As of March 31, 2020, it owned 45 containerships with an aggregate capacity of 248,968 twenty-foot equivalent units. The company is based in London, the United Kingdom.", "industry_name": "Marine", "sector_name": "Industrials", "is_defunct": false, "exchange": "NYSE", "equity_type": "stocks", "market_cap": 75500569, "total_enterprise": 834365569, "number_of_employees": 7, "outstanding_shares": 17806738, "eps": 1.481259, "diluted_eps": 1.475362, "earnings_from_cont_operations": 39838000, "gross_profit": 164294000, "cash": 138024000, "total_debt": 896889000, "total_revenue": 261102000, "cash_from_operations": 93381000, "net_income": 39838000, "ebitda": 153243000, "year_low_stock_price": 2.61, "year_high_stock_price": 9.25, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/GSL.png"}, {"symbol": "PBPB", "name": "Potbelly Corporation", "next_earnings_utc": 1589313900, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 3, "next_earnings_revenue_consensus": 89640610.0, "next_earnings_eps_num_analysts": 3, "next_earnings_eps_consensus": -0.22667, "eps_up_revisions": 0, "eps_down_revisions": 3, "revenue_up_revisions": 0, "revenue_down_revisions": 3, "total_analysts": 3, "analysts_sell": 0, "analysts_buy": 0, "analysts_outperform": 0, "analysts_hold": 2, "analysts_underperform": 1, "webpage": "potbelly.com", "year_founded": 1977, "street_address": "111 North Canal Street", "city": "Chicago", "state": "IL", "zipcode": "60606", "country": "United States", "phone_number": "312 951 0600", "short_description": "Potbelly Corporation, through its subsidiaries, owns, operates, and franchises Potbelly Sandwich Works sandwich shops in the United States.", "long_description": "Potbelly Corporation, through its subsidiaries, owns, operates, and franchises Potbelly Sandwich Works sandwich shops in the United States. The company offers toasty warm sandwiches, salads, soups, chili, sides, desserts, breakfast sandwiches, and steel cut oatmeal. As of February 25, 2020, the company operated approximately 400 shops in the United States; and approximately 40 franchisees operated shops in the United States. The company was formerly known as Potbelly Sandwich Works, Inc. and changed its name to Potbelly Corporation in 2002. Potbelly Corporation was founded in 1977 and is headquartered in Chicago, Illinois.", "industry_name": "Hotels, Restaurants and Leisure", "sector_name": "Consumer Discretionary", "is_defunct": false, "exchange": "NASDAQ", "equity_type": "stocks", "market_cap": 72060826, "total_enterprise": 289620826, "number_of_employees": 6000, "outstanding_shares": 24100611, "eps": -1.005953, "diluted_eps": -1.01, "earnings_from_cont_operations": -23585000, "gross_profit": 114001000, "cash": 18806000, "total_debt": 236045000, "total_revenue": 409707000, "cash_from_operations": 18168000, "net_income": -23992000, "ebitda": 20582000, "year_low_stock_price": 1.5, "year_high_stock_price": 7.0, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/PBPB.png"}, {"symbol": "TESS", "name": "TESSCO Technologies Incorporated", "next_earnings_utc": 1589313900, "next_earnings_has_time": true, "next_earnings_name": "2020 Q4", "next_earnings_year": 2020, "next_earnings_quarter": 4, "next_earnings_revenue_num_analysts": 1, "next_earnings_revenue_consensus": 128858000.0, "next_earnings_eps_num_analysts": 1, "next_earnings_eps_consensus": -0.05, "eps_up_revisions": 1, "eps_down_revisions": 0, "revenue_up_revisions": 0, "revenue_down_revisions": 1, "total_analysts": 1, "analysts_sell": 0, "analysts_buy": 1, "analysts_outperform": 0, "analysts_hold": 0, "analysts_underperform": 0, "webpage": "tessco.com", "year_founded": 1982, "street_address": "11126 McCormick Road", "city": "Hunt Valley", "state": "MD", "zipcode": "21031", "country": "United States", "phone_number": "410-229-1000", "short_description": "TESSCO Technologies Incorporated architects and delivers products and value chain solutions to support wireless systems in the United States.", "long_description": "TESSCO Technologies Incorporated architects and delivers products and value chain solutions to support wireless systems in the United States. The company offers base station infrastructure products, including base station antennas, cable and transmission lines, small towers, lightning protection devices, connectors, power systems, enclosures, grounding, jumpers, miscellaneous hardware products, and mobile antennas to build, repair, and upgrade wireless broadband systems, as well as connector installation, custom jumper assembly, site kitting, and logistics integration services. It also offers network systems products, such as fixed and mobile broadband radio equipment, wireless networking filtering and distributed antenna systems, two-way radios, and security and surveillance products, as well as training classes, technical support, and engineering design services. In addition, the company provides installation, test, and maintenance products comprising analysis equipment; and various frequency, voltage, and power-measuring devices, as well as tools, hardware, GPS and safety products, and replacement and component parts and supplies to install, tune, and maintain wireless communications equipment. Further, it offers mobile devices, such as cellular and smart phones; and data device accessories, including power supplies, cases, screen protectors, speakers, mobile amplifiers, Bluetooth and corded headsets, mounts, car antennas, music accessories, and data and memory cards. The company sells its products to carrier and public network operators, tower owners, program managers, contractors and integrators, private system operators, federal governments, state and local governments, manufacturers, value-added resellers, retail carrier stores and their independent agents, and other retailers under the Ventev, brand. TESSCO Technologies Incorporated was founded in 1982 and is headquartered in Hunt Valley, Maryland.", "industry_name": "Communications Equipment", "sector_name": "Information Technology", "is_defunct": false, "exchange": "NASDAQ", "equity_type": "stocks", "market_cap": 52910553, "total_enterprise": 96915453, "number_of_employees": 796, "outstanding_shares": 8547747, "eps": -0.823227, "diluted_eps": -0.823227, "earnings_from_cont_operations": -7000200, "gross_profit": 102924300, "cash": 800, "total_debt": 44005700, "total_revenue": 557082200, "cash_from_operations": 1993500, "net_income": -7000200, "ebitda": -894500, "year_low_stock_price": 4.23, "year_high_stock_price": 19.64, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/TESS.png"}, {"symbol": "OPNT", "name": "Opiant Pharmaceuticals, Inc.", "next_earnings_utc": 1589313900, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 3, "next_earnings_revenue_consensus": 4849670.0, "next_earnings_eps_num_analysts": 3, "next_earnings_eps_consensus": -0.19333, "eps_up_revisions": null, "eps_down_revisions": null, "revenue_up_revisions": null, "revenue_down_revisions": null, "total_analysts": 2, "analysts_sell": 0, "analysts_buy": 2, "analysts_outperform": 0, "analysts_hold": 0, "analysts_underperform": 0, "webpage": "opiant.com", "year_founded": 2005, "street_address": "233 Wilshirre Boulevard", "city": "Santa Monica", "state": "CA", "zipcode": "90401", "country": "United States", "phone_number": "310 598 5410", "short_description": "Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose.", "long_description": "Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes treatments for opioid overdose; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016. Opiant Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Santa Monica, California.", "industry_name": "Pharmaceuticals", "sector_name": "Health Care", "is_defunct": false, "exchange": "NASDAQ", "equity_type": "stocks", "market_cap": 50184390, "total_enterprise": 19975512, "number_of_employees": 22, "outstanding_shares": 4257605, "eps": 2.884945, "diluted_eps": 2.169999, "earnings_from_cont_operations": 11593050, "gross_profit": 23720169, "cash": 30980473, "total_debt": 771595, "total_revenue": 40519800, "cash_from_operations": 4063890, "net_income": 11593050, "ebitda": 10972296, "year_low_stock_price": 8.05, "year_high_stock_price": 18.23, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/OPNT.png"}, {"symbol": "SSKN", "name": "STRATA Skin Sciences, Inc.", "next_earnings_utc": 1589284800, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 2, "next_earnings_revenue_consensus": 6757000.0, "next_earnings_eps_num_analysts": 3, "next_earnings_eps_consensus": -0.05333, "eps_up_revisions": null, "eps_down_revisions": null, "revenue_up_revisions": 0, "revenue_down_revisions": 2, "total_analysts": 3, "analysts_sell": 0, "analysts_buy": 2, "analysts_outperform": 0, "analysts_hold": 1, "analysts_underperform": 0, "webpage": "strataskinsciences.com", "year_founded": 1989, "street_address": "5 Walnut Grove Drive", "city": "Horsham", "state": "PA", "zipcode": "19044", "country": "United States", "phone_number": "215 619 3200", "short_description": "STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States and Asia.", "long_description": "STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States and Asia. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. Its products include XTRAC excimer laser and VTRAC lamp systems that are used for the treatment of skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. The company distributes its products internationally through distributors, and domestically directly to physicians. STRATA Skin Sciences, Inc. was founded in 1989 and is based in Horsham, Pennsylvania.", "industry_name": "Health Care Equipment and Supplies", "sector_name": "Health Care", "is_defunct": false, "exchange": "NASDAQ", "equity_type": "stocks", "market_cap": 45514695, "total_enterprise": 46051695, "number_of_employees": 115, "outstanding_shares": 33714589, "eps": -0.112525, "diluted_eps": -0.112525, "earnings_from_cont_operations": -3790000, "gross_profit": 20270000, "cash": 8129000, "total_debt": 8666000, "total_revenue": 31586000, "cash_from_operations": 2229000, "net_income": -3790000, "ebitda": 1493000, "year_low_stock_price": 0.752, "year_high_stock_price": 2.92, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/SSKN.png"}, {"symbol": "ISR", "name": "IsoRay, Inc.", "next_earnings_utc": 1589313900, "next_earnings_has_time": true, "next_earnings_name": "2020 Q3", "next_earnings_year": 2020, "next_earnings_quarter": 3, "next_earnings_revenue_num_analysts": 2, "next_earnings_revenue_consensus": 2477000.0, "next_earnings_eps_num_analysts": 2, "next_earnings_eps_consensus": -0.015, "eps_up_revisions": 0, "eps_down_revisions": 0, "revenue_up_revisions": 0, "revenue_down_revisions": 1, "total_analysts": 2, "analysts_sell": 0, "analysts_buy": 1, "analysts_outperform": 1, "analysts_hold": 0, "analysts_underperform": 0, "webpage": "isoray.com", "year_founded": 1983, "street_address": "350 Hills Street", "city": "Richland", "state": "WA", "zipcode": "99354", "country": "United States", "phone_number": "509-375-1202", "short_description": "IsoRay, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States.", "long_description": "IsoRay, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States. The company produces CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers, as well as ocular melanoma. It sells its products to facilities or physician practices that utilize multiple surgical facilities at which primarily prostate brachytherapy procedures are performed. The company was formerly known as Century Park Pictures Corporation and changed its name to IsoRay, Inc. in 2005. IsoRay, Inc. was founded in 1983 and is headquartered in Richland, Washington.", "industry_name": "Biotechnology", "sector_name": "Health Care", "is_defunct": false, "exchange": "NYSEMKT", "equity_type": "stocks", "market_cap": 45325866, "total_enterprise": 43263866, "number_of_employees": 43, "outstanding_shares": 67650547, "eps": -0.058576, "diluted_eps": -0.058576, "earnings_from_cont_operations": -3935000, "gross_profit": 4105000, "cash": 3180000, "total_debt": 1118000, "total_revenue": 8369000, "cash_from_operations": -4254000, "net_income": -3935000, "ebitda": -3838000, "year_low_stock_price": 0.2875, "year_high_stock_price": 1.06, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/ISR.png"}, {"symbol": "LIFE", "name": "aTyr Pharma, Inc.", "next_earnings_utc": 1589313600, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 3, "next_earnings_revenue_consensus": 4399100.0, "next_earnings_eps_num_analysts": 2, "next_earnings_eps_consensus": -0.395, "eps_up_revisions": null, "eps_down_revisions": null, "revenue_up_revisions": null, "revenue_down_revisions": null, "total_analysts": 3, "analysts_sell": 0, "analysts_buy": 1, "analysts_outperform": 1, "analysts_hold": 1, "analysts_underperform": 0, "webpage": "atyrpharma.com", "year_founded": 2005, "street_address": "3545 John Hopkins Court", "city": "San Diego", "state": "CA", "zipcode": "92121", "country": "United States", "phone_number": "858 731 8389", "short_description": "aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States.", "long_description": "aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. Its therapeutic candidate pipeline includes ATYR1923, a fusion protein comprising the immuno-modulatory domain of histidyl tRNA synthetase fused of a human antibody that is in Phase 1b/2a clinical trial. The company has a collaboration with the University of Nebraska Medical Center for the development of NRP2 biology; research collaboration and option agreement with CSL Behring for the development of product candidates derived from up to four tRNA synthetases; and research collaboration with Boston Children's Hospital. It also has license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of ATYR1923 for ILDs in Japan. The company was founded in 2005 and is headquartered in San Diego, California.", "industry_name": "Biotechnology", "sector_name": "Health Care", "is_defunct": false, "exchange": "NASDAQ", "equity_type": "stocks", "market_cap": 36474742, "total_enterprise": 16903742, "number_of_employees": 42, "outstanding_shares": 9352498, "eps": -7.033913, "diluted_eps": -7.033913, "earnings_from_cont_operations": -23763000, "gross_profit": -13626000, "cash": 31144000, "total_debt": 11731000, "total_revenue": 422000, "cash_from_operations": -20013000, "net_income": -23603000, "ebitda": -22343000, "year_low_stock_price": 2.13, "year_high_stock_price": 8.4, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/LIFE.png"}, {"symbol": "PEIX", "name": "Pacific Ethanol, Inc.", "next_earnings_utc": 1589313900, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 2, "next_earnings_revenue_consensus": 269794000.0, "next_earnings_eps_num_analysts": 2, "next_earnings_eps_consensus": -0.575, "eps_up_revisions": 0, "eps_down_revisions": 1, "revenue_up_revisions": 0, "revenue_down_revisions": 1, "total_analysts": 2, "analysts_sell": 0, "analysts_buy": 1, "analysts_outperform": 1, "analysts_hold": 0, "analysts_underperform": 0, "webpage": "pacificethanol.com", "year_founded": 2003, "street_address": "400 Capitol Mall", "city": "Sacramento", "state": "CA", "zipcode": "95814", "country": "United States", "phone_number": "916 403 2123", "short_description": "Pacific Ethanol, Inc. produces and markets low-carbon renewable fuels and alcohol products in the United States.", "long_description": "Pacific Ethanol, Inc. produces and markets low-carbon renewable fuels and alcohol products in the United States. The company operates in two segments, Production and Marketing. It produces and markets ethanol; and co-products, such as wet and dry distillers grains, wet and dry corn gluten feed, condensed distillers solubles, corn gluten meal, corn germ, corn oil, dried yeast, and CO2, as well as markets ethanol produced by third parties. The company also offers ethanol transportation, storage, and delivery services through third-party service providers. It sells ethanol to integrated oil companies and gasoline marketers; distillers grains and other feed co-products to dairies and feedlots; and corn oil to poultry and biodiesel customers. The company owns and operates nine ethanol production facilities, including four plants located in the Western states of California, Oregon, and Idaho; and five plants in the Midwestern states of Illinois and Nebraska. Pacific Ethanol, Inc. was founded in 2003 and is headquartered in Sacramento, California.", "industry_name": "Oil, Gas and Consumable Fuels", "sector_name": "Energy", "is_defunct": false, "exchange": "NASDAQ", "equity_type": "stocks", "market_cap": 23223919, "total_enterprise": 279915919, "number_of_employees": 500, "outstanding_shares": 55893910, "eps": -1.903891, "diluted_eps": -1.903891, "earnings_from_cont_operations": -101282000, "gross_profit": -9938000, "cash": 18997000, "total_debt": 268423000, "total_revenue": 1424881000, "cash_from_operations": -23363000, "net_income": -88949000, "ebitda": -4582000, "year_low_stock_price": 0.22, "year_high_stock_price": 1.31, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/PEIX.png"}, {"symbol": "VTSI", "name": "VirTra, Inc.", "next_earnings_utc": 1589313900, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 1, "next_earnings_revenue_consensus": 4830000.0, "next_earnings_eps_num_analysts": 1, "next_earnings_eps_consensus": -0.02, "eps_up_revisions": 0, "eps_down_revisions": 1, "revenue_up_revisions": 1, "revenue_down_revisions": 0, "total_analysts": 1, "analysts_sell": 0, "analysts_buy": 1, "analysts_outperform": 0, "analysts_hold": 0, "analysts_underperform": 0, "webpage": "virtra.com", "year_founded": 1993, "street_address": "7970 South Kyrene Road", "city": "Tempe", "state": "AZ", "zipcode": "85284", "country": "United States", "phone_number": "480-968-1488", "short_description": "VirTra, Inc. develops, sells, and supports use of force training and marksmanship firearms training systems and accessories for law enforcement, military, educational, and civilian use worldwide.", "long_description": "VirTra, Inc. develops, sells, and supports use of force training and marksmanship firearms training systems and accessories for law enforcement, military, educational, and civilian use worldwide. Its products comprise V-300 simulator, a 300 degree wrap-around screen for simulation training; V-180 simulator, a 180 degree screen for smaller spaces and budgets; V-100, a single-screen based simulator system; V-100 MIL, a single-screen small arms training simulator; V-ST, a realistic single screen simulated shooting range simulator; and Top Subject Mater Expert Content, a content supplied with its simulators. The company also offers V-Author, a software that allows users to create, edit, and train with content specific to agency\u00e2\u20ac\u2122s objectives; Simulated Recoil, a range of realistic and reliable simulated recoil kits/weapons; and Threat-Fire, a return fire device that applies real-world stress on the trainees during simulation training. It sells its simulators and related products through a direct sales force and distribution partners. The company was formerly known as VirTra Systems, Inc. and changed its name to VirTra, Inc. in October 2016. VirTra, Inc. was founded in 1993 and is headquartered in Tempe, Arizona.", "industry_name": "Aerospace and Defense", "sector_name": "Industrials", "is_defunct": false, "exchange": "NASDAQ", "equity_type": "stocks", "market_cap": 18433171, "total_enterprise": 16575206, "number_of_employees": 88, "outstanding_shares": 7745030, "eps": -0.009716, "diluted_eps": -0.01, "earnings_from_cont_operations": -75277, "gross_profit": 9713691, "cash": 3330091, "total_debt": 1472126, "total_revenue": 18711923, "cash_from_operations": -1432351, "net_income": -75277, "ebitda": 678444, "year_low_stock_price": 2.0, "year_high_stock_price": 5.3, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/VTSI.png"}, {"symbol": "GEVO", "name": "Gevo, Inc.", "next_earnings_utc": 1589313900, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 2, "next_earnings_revenue_consensus": 3399000.0, "next_earnings_eps_num_analysts": 2, "next_earnings_eps_consensus": -0.445, "eps_up_revisions": 0, "eps_down_revisions": 0, "revenue_up_revisions": 0, "revenue_down_revisions": 1, "total_analysts": 2, "analysts_sell": 0, "analysts_buy": 1, "analysts_outperform": 1, "analysts_hold": 0, "analysts_underperform": 0, "webpage": "gevo.com", "year_founded": 2005, "street_address": "Building C", "city": "Englewood", "state": "CO", "zipcode": "80112", "country": "United States", "phone_number": "303 858 8358", "short_description": "Gevo, Inc. develops and commercializes jet fuel, gasoline, and diesel fuel in the United States.", "long_description": "Gevo, Inc. develops and commercializes jet fuel, gasoline, and diesel fuel in the United States. It operates through two segments, Gevo, Inc. and Gevo Development/Agri-Energy. The company engages in the research, development, and production of isobutanol; development of its proprietary biocatalysts; production and sale of renewable jet and other fuels; and retrofit process of chemicals and biofuels. It is also involved in the production of ethanol, isobutanol, and related products. The company's products are used to zero carbon achieve emissions; and reduce greenhouse gas emissions. In addition, the company also engages in the development of isobutanol through fermentation of renewable plant biomass. The company was formerly known as Methanotech, Inc. and changed its name to Gevo, Inc. in March 2006. Gevo, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.", "industry_name": "Oil, Gas and Consumable Fuels", "sector_name": "Energy", "is_defunct": false, "exchange": "NASDAQ", "equity_type": "stocks", "market_cap": 14628644, "total_enterprise": 13675644, "number_of_employees": 55, "outstanding_shares": 13545041, "eps": -2.353442, "diluted_eps": -2.353442, "earnings_from_cont_operations": -28660000, "gross_profit": -12246000, "cash": 16302000, "total_debt": 15349000, "total_revenue": 24487000, "cash_from_operations": -20839000, "net_income": -28660000, "ebitda": -19695000, "year_low_stock_price": 0.61, "year_high_stock_price": 3.6, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/GEVO.png"}, {"symbol": "CHFS", "name": "CHF Solutions, Inc.", "next_earnings_utc": 1589284800, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 1, "next_earnings_revenue_consensus": 1570000.0, "next_earnings_eps_num_analysts": 1, "next_earnings_eps_consensus": -0.78, "eps_up_revisions": 0, "eps_down_revisions": 1, "revenue_up_revisions": 0, "revenue_down_revisions": 1, "total_analysts": 1, "analysts_sell": 0, "analysts_buy": 1, "analysts_outperform": 0, "analysts_hold": 0, "analysts_underperform": 0, "webpage": "chf-solutions.com", "year_founded": 1999, "street_address": "12988 Valley View Road", "city": "Eden Prairie", "state": "MN", "zipcode": "55344", "country": "United States", "phone_number": "952 345 4200", "short_description": "CHF Solutions, Inc., a medical device company, focuses on developing, manufacturing, and commercializing devices used in ultrafiltration therapy.", "long_description": "CHF Solutions, Inc., a medical device company, focuses on developing, manufacturing, and commercializing devices used in ultrafiltration therapy. The company's commercial product is the Aquadex FlexFlow System, which is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct Salesforce in the United States; and through independent specialty distributors primarily in the United Kingdom, Italy, Spain, Germany, Austria, Switzerland, Southeast Asia, Brazil, India, and Greece. The company was formerly known as Sunshine Heart, Inc. and changed its name to CHF Solutions, Inc. in May 2017. CHF Solutions, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.", "industry_name": "Health Care Equipment and Supplies", "sector_name": "Health Care", "is_defunct": false, "exchange": "NASDAQ", "equity_type": "stocks", "market_cap": 15077289, "total_enterprise": 14245289, "number_of_employees": 66, "outstanding_shares": 38669633, "eps": -9.298397, "diluted_eps": -9.298397, "earnings_from_cont_operations": -18114000, "gross_profit": 2851000, "cash": 1279000, "total_debt": 447000, "total_revenue": 5511000, "cash_from_operations": -16367000, "net_income": -18114000, "ebitda": -17867000, "year_low_stock_price": 0.3, "year_high_stock_price": 3.81, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/CHFS.png"}, {"symbol": "FTEK", "name": "Fuel Tech, Inc.", "next_earnings_utc": 1589317800, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 1, "next_earnings_revenue_consensus": 4774000.0, "next_earnings_eps_num_analysts": 1, "next_earnings_eps_consensus": -0.1, "eps_up_revisions": null, "eps_down_revisions": null, "revenue_up_revisions": null, "revenue_down_revisions": null, "total_analysts": 1, "analysts_sell": 0, "analysts_buy": 0, "analysts_outperform": 0, "analysts_hold": 1, "analysts_underperform": 0, "webpage": "ftek.com", "year_founded": 1987, "street_address": "27601 Bella Vista Parkway", "city": "Warrenville", "state": "IL", "zipcode": "60555-1617", "country": "United States", "phone_number": "630 845 4500", "short_description": "Fuel Tech, Inc. provides boiler optimization, efficiency improvement, and air pollution reduction and control solutions to utility and industrial customers worldwide.", "long_description": "Fuel Tech, Inc. provides boiler optimization, efficiency improvement, and air pollution reduction and control solutions to utility and industrial customers worldwide. It operates through Air Pollution Control Technology and FUEL CHEM Technology segments. The Air Pollution Control Technology segment offers technologies to reduce nitrogen oxide (NOx) emissions in flue gas from boilers, incinerators, furnaces, and other stationary combustion sources, which includes low and ultra-low NOx burners; over-fire air systems; NOxOUT and HERT selective non-catalytic reduction systems; advanced selective catalytic reduction systems comprising ULNB, OFA, and SNCR components, as well as downsized SCR catalyst, Ammonia Injection Grid, and Graduated Straightening Grid systems; NOxOUT CASCADE and NOxOUT-SCR processes; ULTRA technology; and flue gas conditioning systems. The FUEL CHEM Technology segment provides programs to improve the efficiency, reliability, fuel flexibility, boiler heat rate, and environmental status of combustion units by controlling slagging, fouling, corrosion, opacity, and acid plume, as well as the formation of sulfur trioxide, ammonium bisulfate, particulate matter, sulfur dioxide, and carbon dioxide through the addition of chemicals into the furnace using TIFI targeted in-furnace injection technology. This segment offers its FUEL CHEM program for plants operating in the electric utility, industrial, pulp and paper, waste-to-energy, university, and district heating markets, as well as to the owners of boilers, furnaces, and other combustion units. The company was founded in 1987 and is headquartered in Warrenville, Illinois.", "industry_name": "Commercial Services and Supplies", "sector_name": "Industrials", "is_defunct": false, "exchange": "NASDAQ", "equity_type": "stocks", "market_cap": 22378679, "total_enterprise": 12444679, "number_of_employees": 82, "outstanding_shares": 24591955, "eps": -0.324435, "diluted_eps": -0.324435, "earnings_from_cont_operations": -7851000, "gross_profit": 10830000, "cash": 10914000, "total_debt": 980000, "total_revenue": 30467000, "cash_from_operations": -3387000, "net_income": -7852000, "ebitda": -6492000, "year_low_stock_price": 0.3, "year_high_stock_price": 2.69, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/FTEK.png"}, {"symbol": "CYCC", "name": "Cyclacel Pharmaceuticals, Inc.", "next_earnings_utc": 1589313900, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 2, "next_earnings_revenue_consensus": 0.0, "next_earnings_eps_num_analysts": 1, "next_earnings_eps_consensus": -2.8, "eps_up_revisions": null, "eps_down_revisions": null, "revenue_up_revisions": null, "revenue_down_revisions": null, "total_analysts": 2, "analysts_sell": 0, "analysts_buy": 1, "analysts_outperform": 1, "analysts_hold": 0, "analysts_underperform": 0, "webpage": "cyclacel.com", "year_founded": 1992, "street_address": "200 Connell Drive", "city": "Berkeley Heights", "state": "NJ", "zipcode": "07922", "country": "United States", "phone_number": "908 517 7330", "short_description": "Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases.", "long_description": "Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's oncology development programs include CYC065, a cyclin dependent kinase Inhibitors (CDK) that is in Phase I clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and CYC140, a polo-like kinase inhibitor program, which is in Phase I clinical trial for the treatment of advanced leukemias. Its oncology development programs also comprise sapacitabine, an oral nucleoside analogue prodrug that is in Phase 1/2 combination study with seliciclib, a CDK inhibitor in patients with BRCA mutations; with olaparib, a poly ADP-ribose polymerase inhibitor in BRCA mutation positive patients with breast cancer; and Phase III clinical trial for the treatment of acute myeloid leukemia. In addition, the company's oncology development programs include seliciclib, a CDK inhibitor that is in all-oral Phase 1/2 combination study with sapacitabine for BRCA mutations. It has a clinical collaboration agreement with the University of Texas MD Anderson Cancer Center to clinically evaluate the safety and efficacy of three cyclacel medicines in patients with hematological malignancies, including chronic lymphocytic leukemias, acute myeloid leukemias, myelodysplastic syndromes, and other advanced leukemias; and collaboration, licensing, and supply agreement with ManRos Therapeutics SA for the development and commercialization of oral seliciclib capsules for the treatment of cystic fibrosis. Cyclacel Pharmaceuticals, Inc. was founded in 1992 and is headquartered in Berkeley Heights, New Jersey.", "industry_name": "Biotechnology", "sector_name": "Health Care", "is_defunct": false, "exchange": "NASDAQ", "equity_type": "stocks", "market_cap": 20023191, "total_enterprise": 9329191, "number_of_employees": 12, "outstanding_shares": 4859998, "eps": -9.840862, "diluted_eps": -9.840862, "earnings_from_cont_operations": -7830000, "gross_profit": -4658000, "cash": 11885000, "total_debt": 1191000, "total_revenue": 150000, "cash_from_operations": -9447000, "net_income": -7830000, "ebitda": -9662000, "year_low_stock_price": 3.85, "year_high_stock_price": 20.4, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/CYCC.png"}, {"symbol": "NSPR", "name": "InspireMD, Inc.", "next_earnings_utc": 1589284800, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 1, "next_earnings_revenue_consensus": 1000000.0, "next_earnings_eps_num_analysts": 1, "next_earnings_eps_consensus": -0.63, "eps_up_revisions": null, "eps_down_revisions": null, "revenue_up_revisions": null, "revenue_down_revisions": null, "total_analysts": 1, "analysts_sell": 0, "analysts_buy": 0, "analysts_outperform": 1, "analysts_hold": 0, "analysts_underperform": 0, "webpage": "inspiremd.com", "year_founded": null, "street_address": "4 Menorat Hamaor Street", "city": "Tel Aviv", "state": null, "zipcode": "6744832", "country": "Israel", "phone_number": "972 3 6917691", "short_description": "InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular diseases.", "long_description": "InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular diseases. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. It is also developing NGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms in order to seal the aneurysms. InspireMD, Inc. distributes its products in Europe, Latin America, the Middle East, and Asia. The company is headquartered in Tel Aviv, Israel.", "industry_name": "Health Care Equipment and Supplies", "sector_name": "Health Care", "is_defunct": false, "exchange": "NYSEMKT", "equity_type": "stocks", "market_cap": 3210355, "total_enterprise": -1288645, "number_of_employees": 48, "outstanding_shares": 4338910, "eps": -4.80391, "diluted_eps": -4.80391, "earnings_from_cont_operations": -10040000, "gross_profit": 756000, "cash": 5514000, "total_debt": 1015000, "total_revenue": 3721000, "cash_from_operations": -9810000, "net_income": -10040000, "ebitda": -9658000, "year_low_stock_price": 0.48, "year_high_stock_price": 5.3, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/NSPR.png"}, {"symbol": "RCMT", "name": "RCM Technologies, Inc.", "next_earnings_utc": 1589284800, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 2, "next_earnings_revenue_consensus": 49292500.0, "next_earnings_eps_num_analysts": 1, "next_earnings_eps_consensus": 0.07, "eps_up_revisions": 0, "eps_down_revisions": 1, "revenue_up_revisions": 0, "revenue_down_revisions": 2, "total_analysts": 2, "analysts_sell": 0, "analysts_buy": 1, "analysts_outperform": 0, "analysts_hold": 1, "analysts_underperform": 0, "webpage": "rcmt.com", "year_founded": 1971, "street_address": "2500 McClellan Avenue", "city": "Pennsauken", "state": "NJ", "zipcode": "08109-4613", "country": "United States", "phone_number": "856 356 4500", "short_description": "RCM Technologies, Inc. provides business and technology solutions in the United States, Canada, Puerto Rico, and Serbia.", "long_description": "RCM Technologies, Inc. provides business and technology solutions in the United States, Canada, Puerto Rico, and Serbia. It operates through three segments: Engineering, Specialty Health Care, and Information Technology. The Engineering segment offers a range of engineering services, including project management engineering and design, engineering analysis, engineer-procure-construct, configuration management, hardware/software validation and verification, quality assurance, technical writing and publications, manufacturing process planning and improvement, and 3D/BIM integrated design. The Specialty Health Care segment provides long-term and short-term staffing, executive search, and placement services in the fields of rehabilitation, including physical therapists, occupational therapists, and speech language pathologists; nursing; managed care; allied health care; health care management; medical office support; and non-medical caregivers or companions. This segment also offers in-patient, outpatient, sub-acute and acute care, multilingual speech pathology, rehabilitation, geriatric, pediatric, and adult day care services to hospitals, long-term care facilities, schools, sports medicine facilities, and private practices. The Information Technology segment provides enterprise business solutions, application services, infrastructure solutions, competitive advantage and productivity solutions, life sciences solutions, and other vertical market specific solutions. The company serves aerospace and defense, energy, financial services, health care, life sciences, manufacturing and distribution, and technology industries, as well as educational institutions and the public sector. RCM Technologies, Inc. was founded in 1971 and is headquartered in Pennsauken, New Jersey.", "industry_name": "Professional Services", "sector_name": "Industrials", "is_defunct": false, "exchange": "NASDAQ", "equity_type": "stocks", "market_cap": 19998200, "total_enterprise": 59471200, "number_of_employees": 3410, "outstanding_shares": 13135970, "eps": 0.314234, "diluted_eps": 0.309999, "earnings_from_cont_operations": 4058000, "gross_profit": 48592000, "cash": 1847000, "total_debt": 41320000, "total_revenue": 191100000, "cash_from_operations": -4778000, "net_income": 4058000, "ebitda": 8155000, "year_low_stock_price": 1.02, "year_high_stock_price": 4.17, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/RCMT.png"}, {"symbol": "OSMT", "name": "Osmotica Pharmaceuticals plc", "next_earnings_utc": 1589313900, "next_earnings_has_time": true, "next_earnings_name": "2020 Q1", "next_earnings_year": 2020, "next_earnings_quarter": 1, "next_earnings_revenue_num_analysts": 5, "next_earnings_revenue_consensus": 45491600.0, "next_earnings_eps_num_analysts": 3, "next_earnings_eps_consensus": -0.15667, "eps_up_revisions": 2, "eps_down_revisions": 0, "revenue_up_revisions": 1, "revenue_down_revisions": 0, "total_analysts": 6, "analysts_sell": 0, "analysts_buy": 3, "analysts_outperform": 2, "analysts_hold": 1, "analysts_underperform": 0, "webpage": "osmotica.com", "year_founded": null, "street_address": "400 Crossing Boulevard", "city": "Bridgewater", "state": "NJ", "zipcode": "08807", "country": "United States", "phone_number": "908 809 1300", "short_description": "Osmotica Pharmaceuticals plc, an integrated biopharmaceutical company, focuses on the development and commercialization of pharmaceutical products in the United States, Argentina, and Hungary.", "long_description": "Osmotica Pharmaceuticals plc, an integrated biopharmaceutical company, focuses on the development and commercialization of pharmaceutical products in the United States, Argentina, and Hungary. The company's promoted products include M-72, a methylphenidate hydrochloride extended-release tablet to treat attention deficit hyperactivity disorder (ADHD); Osmolex ER, an amantadine extended-release tablet for the treatment of Parkinson's and drug-induced extrapyramidal reactions in adults; Lorzone, a chlorzoxazone scored tablet for muscle spasms; ConZip, a tramadol hydrochloride extended-release capsule to treat pain; and Arbaclofen tablets which is in phase III clinical trial for the treatment of multiple sclerosis spasticity. It also provides women's health products, including Divigel for menopause, as well as OB Complete, a dietary supplement for prenatal, pregnancy, and postnatal periods; and RVL-1201, an oxymetazoline hydrochloride ophthalmic solution for the treatment of Blepharoptosis. In addition, the company's non-promoted products comprise methylphenidate ER tablets for ADHD; venlafaxine ER tablets to treat major depressive disorder and social anxiety disorder; hydromorphone ER for treating pain; nifedipine ER for hypertension; sodium benzoate/sodium phenylacetate for the treatment of hyperammonemia; oxybutynin ER for overactive bladder; and prescription prenatal vitamins for treating nutritional requirements during pregnancy, as well as Osmodex and other abbreviated new drug applications. Osmotica Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.", "industry_name": "Pharmaceuticals", "sector_name": "Health Care", "is_defunct": false, "exchange": "NASDAQ", "equity_type": "stocks", "market_cap": 242662676, "total_enterprise": 420096676, "number_of_employees": 379, "outstanding_shares": 58898708, "eps": -5.17308, "diluted_eps": -5.17308, "earnings_from_cont_operations": -270901000, "gross_profit": 128401000, "cash": 95865000, "total_debt": 273299000, "total_revenue": 240031000, "cash_from_operations": 33567000, "net_income": -270901000, "ebitda": 54099000, "year_low_stock_price": 2.2, "year_high_stock_price": 7.97, "image_url": "https://raw.githubusercontent.com/earnbros/earnbros.github.io/master/api/images/companies/OSMT.png"}]